Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027923	s-c-pept	nmol/l (nmol/l)	1086	1452	0.00%
3027923	p-c-pept	nmol/l (nmol/l)	790	1597	0.00%
3027923	p-c-pept	— (—)	464	589	100.00%	Distribution not available
3027923	s-c-pept	— (—)	240	270	100.00%	Distribution not available
3027923	p-c-peptidi	nmol/l (nmol/l)	126	171	0.00%
3027923	p-c-peptidi	— (—)	21	21	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Thiazolidinediones

202

35.10

319.86

1.3

1.6

1.24

1.33

nmol/l

0.16

145

Diabetic maculopathy, excluding more controls

180

47.82

308.45

1.4

2.2

0.76

1.43

nmol/l

3.36

115

Diabetes medication

1608

343

28.01

307.65

1.5

2.6

1.23

1.45

nmol/l

3.22

1209

298

Other blood glucose lowering drugs, excl. Insulins

328

38.13

307.65

1.4

1.5

1.10

1.27

nmol/l

0.55

245

Type 1 diabetes

394

42.18

307.65

1.5

2.8

0.62

1.52

nmol/l

13.22

287

Type 2 diabetes

1436

277

30.67

307.65

1.5

2.8

1.28

1.43

nmol/l

1.44

1082

243

Insulin, intermediate and long-acting

1540

627

24.90

307.65

1.4

1.7

1.03

1.59

nmol/l

23.47

1117

511

Type 2 diabetes, wide definition

1275

269

30.67

307.65

1.3

2.1

1.27

1.22

nmol/l

0.28

958

225

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1075

302

28.91

307.65

1.3

1.7

1.26

1.29

nmol/l

0.15

786

240

Combinations of oral blood glucose lowering drugs

517

186

28.86

307.65

1.3

1.7

1.22

1.24

nmol/l

0.05

396

145

Other (not insulin) diabetes medications

1494

314

28.57

307.65

1.4

2.5

1.29

1.46

nmol/l

1.69

1122

270

Insulin, fast-acting or short human

937

695

14.10

307.65

1.5

1.6

0.83

1.49

nmol/l

36.17

687

531

Diabetes, insulin treatment (Kela reimbursement)

1659

398

25.42

307.65

1.4

2.4

1.19

1.54

nmol/l

6.72

1235

337

Endocrine, nutritional and metabolic diseases

607

135

22.93

307.65

1.7

2.4

1.28

1.36

nmol/l

0.36

456

116

Glucagon-like peptide-1 (GLP-1) analogues

737

224

34.47

307.65

1.3

2.1

1.41

1.30

nmol/l

0.61

530

179

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

737

224

34.47

307.65

1.3

2.1

1.41

1.30

nmol/l

0.61

530

179

Insulin medication

1619

250

56.23

307.65

1.4

2.3

1.06

1.49

nmol/l

7.09

1179

211

Diabetes mellitus

1481

296

29.51

307.65

1.5

2.8

1.22

1.43

nmol/l

2.61

1119

260

Insulin, fast-acting

933

402

24.34

307.65

1.5

1.8

0.83

1.61

nmol/l

31.95

684

333

Type 2 diabetes, definitions combined, including avohilmo

1227

256

28.25

307.65

1.5

2.7

1.40

1.42

nmol/l

0.09

930

226

Biguanides

1441

459

19.38

307.65

1.4

2.1

1.31

1.27

nmol/l

0.30

1078

371

Type 1 diabetes, wide definition, subgroup 1

320

41.66

307.65

1.5

3.0

0.52

1.58

nmol/l

13.93

228

Sulfonylureas

565

158

29.31

307.65

1.3

1.4

0.96

1.31

nmol/l

2.66

399

126

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1581

252

38.18

307.65

1.4

2.6

1.19

1.41

nmol/l

2.63

1182

220

Type 2 diabetes, strict (exclude DM1)

1260

276

27.09

307.65

1.4

2.6

1.39

1.40

nmol/l

0.03

955

239

Type 2 diabetes, definitions combined

1254

257

28.95

307.65

1.4

2.7

1.39

1.42

nmol/l

0.15

950

224

Diabetes, varying definitions

1469

307

28.33

307.65

1.5

2.8

1.23

1.40

nmol/l

1.96

1112

266

Insulin, combination of fast acting with intermediate-acting or long-acting

1619

661

23.21

307.65

1.4

1.8

1.06

1.59

nmol/l

22.38

1179

539

Type 1 diabetes, wide definition

325

40.70

307.65

1.5

2.9

0.53

1.56

nmol/l

13.96

233

Sub-endpoint used in defining T1D endpoints

413

622

6.68

254.80

1.5

1.6

0.62

1.36

nmol/l

31.80

300

472

Obesity due to excess calories

508

1126

4.58

209.93

2.0

1.5

1.62

1.15

nmol/l

12.34

382

862

Other nutritional deficiencies

620

1512

3.79

194.03

1.9

1.5

1.58

1.18

nmol/l

10.74

472

1153

Obesity and other hyperalimentation

595

1475

3.84

191.18

1.9

1.5

1.60

1.18

nmol/l

11.15

447

1133

Obesity

592

1471

3.83

190.07

1.9

1.5

1.60

1.18

nmol/l

11.19

445

1129

Any reimbursement code in KELA

327

174

9.49

186.72

1.6

3.5

1.29

1.73

nmol/l

4.29

249

160

Cardiac arrhythmias

249

163

9.84

169.67

1.7

3.2

1.26

1.50

nmol/l

1.62

197

150

Statin medication

466

547

4.83

165.66

1.5

2.1

1.29

1.33

nmol/l

0.28

344

445

Hypertension, essential

558

838

3.79

149.22

1.6

1.7

1.25

1.28

nmol/l

0.20

421

647

Hypertension

561

848

3.76

148.14

1.6

1.7

1.27

1.29

nmol/l

0.15

419

655

Hypertensive diseases

561

849

3.76

147.95

1.6

1.7

1.27

1.29

nmol/l

0.13

419

656

Special screening examination for other diseases and disorders

165

167

10.11

144.80

1.4

1.6

0.99

1.33

nmol/l

2.80

135

145

Hypertensive diseases (excluding secondary)

394

494

4.68

137.35

1.6

1.9

1.29

1.30

nmol/l

0.05

292

385

Elevated blood glucose level

163

191

8.88

128.62

1.7

1.4

1.12

1.20

nmol/l

0.29

129

144

Chronic pancreatitis

195

294

6.84

123.42

1.5

1.3

0.85

1.23

nmol/l

4.66

147

218

Medical observation and evaluation for suspected diseases and conditions

449

578

4.00

123.37

1.7

1.6

1.30

1.26

nmol/l

0.21

281

478

Other disorders of glucose regulation and pancreatic internal secretion

151

174

8.99

120.66

2.2

1.4

1.09

1.30

nmol/l

0.84

116

130

Metabolic disorders

672

1426

2.85

118.68

1.5

1.6

1.22

1.28

nmol/l

0.63

516

1085

Hypoglycaemia, other or unspecified

121

133

9.44

100.33

2.5

1.5

1.15

1.31

nmol/l

0.49

103

All chronic kidney diseases

421

1068

3.17

97.24

1.5

1.26

1.28

nmol/l

0.07

309

799

Type 1 diabetes, strict (exclude DM2)

20.53

95.74

1.8

3.6

0.38

1.61

nmol/l

8.33

Heart failure, not strict

526

1261

2.82

95.00

1.5

1.4

1.36

1.22

nmol/l

1.68

379

959

Other retinal disorders

485

1294

2.87

93.30

1.5

1.4

0.94

1.33

nmol/l

10.77

325

998

General examination and investigation of persons without complaint and reported diagnosis

391

577

3.54

92.53

1.6

1.29

1.26

nmol/l

0.12

289

477

Pure hypercholesterolaemia

529

1214

2.79

91.72

1.5

1.4

1.26

1.25

nmol/l

0.06

395

920

Disorders of lipoprotein metabolism and other lipidaemias

566

1287

2.69

90.89

1.5

1.4

1.26

nmol/l

0.04

424

977

Obesity, other/unspecified

272

715

3.85

89.78

2.1

1.5

1.62

1.14

nmol/l

6.34

202

543

Sleep apnoea

631

1599

2.50

88.84

1.6

1.5

1.45

1.20

nmol/l

5.15

446

1248

Neurological diseases, wide definition

136

11.84

87.74

1.9

3.4

1.37

1.32

nmol/l

0.11

105

Implicit Sepsis

519

1459

2.64

84.70

1.5

1.32

1.28

nmol/l

0.27

390

1102

Autoimmune diseases excluding thyroid diseases

661

1491

2.41

82.86

1.5

1.6

1.01

1.42

nmol/l

14.02

498

1148

Nerve, nerve root and plexus disorders

685

1781

2.32

81.21

1.5

1.6

1.23

1.30

nmol/l

0.92

520

1357

Disorders of gallbladder, biliary tract and pancreas

633

1674

2.37

79.00

1.6

1.5

1.17

1.32

nmol/l

2.60

511

1244

Insulin, fast-acting (human)

105

130

8.18

78.89

1.7

2.1

0.54

1.61

nmol/l

13.62

102

Cardiovascular diseases (excluding rheumatic etc)

358

633

3.25

77.90

1.7

2.1

1.29

1.32

nmol/l

0.16

278

502

Implicit Sepsis, including avohilmo

538

1554

2.49

77.50

1.4

1.6

1.31

1.28

nmol/l

0.16

407

1183

Autoimmune diseases excluding thyroid diseases, strict definition

631

1452

2.38

76.53

1.5

1.6

1.01

1.41

nmol/l

13.39

476

1118

Sleep apnoea, including avohilmo

627

1630

2.34

75.70

1.7

1.5

1.45

1.19

nmol/l

5.83

445

1270

Disorders of choroid and retina

532

1558

2.40

71.00

1.5

1.01

1.33

nmol/l

7.15

356

1208

Heart failure and antihypertensive medication

165

199

5.44

70.91

1.4

1.6

1.43

1.17

nmol/l

1.35

113

156

All kidney diseases

605

1788

2.28

70.81

1.5

1.6

1.34

1.26

nmol/l

0.85

450

1384

Other special examinations and investigations of persons without complaint or reported diagnosis

357

578

3.14

70.61

1.5

1.6

1.15

1.26

nmol/l

1.00

274

478

Renal tubulo-interstitial diseases

545

1702

2.36

70.55

1.5

1.6

1.33

1.27

nmol/l

0.40

411

1302

Implicit bacterial Sepsis, including avohilmo

332

943

2.95

68.99

1.4

1.33

1.24

nmol/l

0.49

254

698

Autoimmune diseases

656

1494

2.24

68.39

1.6

1.07

1.41

nmol/l

9.97

485

1151

Condition for Implicit Sepsis (Organ dysfunction codes)

532

1578

2.35

67.27

1.4

1.6

1.29

1.28

nmol/l

0.09

404

1209

Acute pancreatitis

184

453

4.12

66.79

1.6

1.4

0.93

1.25

nmol/l

4.03

148

334

Abnormalities of breathing

543

1327

2.35

65.55

1.6

1.37

1.23

nmol/l

1.66

409

1021

Implicit bacterial Sepsis

305

885

2.98

64.95

1.4

1.30

1.22

nmol/l

0.48

234

657

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

543

1611

2.29

64.29

1.5

1.6

1.25

1.29

nmol/l

0.31

409

1232

Bacterial Sepsis

332

976

2.83

64.07

1.4

1.27

1.25

nmol/l

0.12

250

727

Renal failure

345

1072

2.76

63.99

1.4

1.39

1.21

nmol/l

1.39

251

800

Antihypertensive medication - note that there are other indications

296

475

3.27

63.01

1.8

2.1

1.45

1.21

nmol/l

2.14

228

393

Persons encountering health services for specific procedures and health care

622

1731

2.13

60.12

1.5

1.6

1.24

1.30

nmol/l

0.65

483

1312

Type 1 diabetes, strict definition, subgroup 1

20.65

59.11

2.0

3.8

0.32

1.81

nmol/l

6.02

Acute pancreatitis (for exclusion)

184

496

3.76

58.89

1.6

1.4

0.93

1.21

nmol/l

3.43

148

366

Other heart diseases

252

499

3.30

58.79

1.6

1.9

1.29

1.31

nmol/l

0.08

187

388

STROKE

266

569

3.16

58.73

1.5

1.6

1.14

1.43

nmol/l

3.76

211

434

Acute renal failure

187

512

3.70

58.47

1.3

1.4

1.41

1.14

nmol/l

1.57

135

384

Type 1 diabetes, strict definition

18.56

57.65

2.0

3.9

0.32

1.78

nmol/l

7.06

Used for control exclusion in common control thyroid runs

597

1396

2.17

57.59

1.6

1.08

1.41

nmol/l

8.88

445

1080

Alcohol-induced chronic pancreatitis

149

6.51

56.92

1.4

0.83

1.24

nmol/l

2.96

108

Other disorders of fluid, electrolyte and acid-base balance

224

657

3.24

56.37

1.4

1.3

1.28

1.22

nmol/l

0.29

169

490

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

578

1860

2.10

56.01

1.5

1.6

1.31

1.28

nmol/l

0.22

436

1421

Other bacterial diseases, including avohilmo

587

1748

2.10

55.95

1.5

1.6

1.22

1.30

nmol/l

0.73

433

1340

Other bacterial diseases

558

1741

2.13

55.73

1.5

1.19

1.30

nmol/l

1.27

411

1334

Diseases of oesophagus, stomach and duodenum

617

1774

2.06

54.98

1.7

1.6

1.24

1.30

nmol/l

0.48

464

1364

Implicit viral Sepsis

165

449

3.72

52.09

1.5

1.37

1.19

nmol/l

1.02

115

328

Viral Sepsis

165

449

3.72

52.09

1.5

1.37

1.19

nmol/l

1.02

115

328

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

557

1703

2.07

51.39

1.5

1.6

1.19

1.31

nmol/l

1.51

404

1338

Glomerular disorders in diseases classified elsewhere

121

265

4.65

51.28

1.7

1.4

1.17

1.28

nmol/l

0.38

190

Concussion

278

780

2.78

51.16

1.6

1.7

1.27

1.23

nmol/l

0.19

205

631

Chronic kidney disease

227

734

3.00

50.53

1.5

1.3

1.46

1.18

nmol/l

1.82

162

545

Diseases of arteries, arterioles and capillaries (FINNGEN)

152

252

4.20

50.37

1.5

1.17

1.30

nmol/l

0.69

110

186

Persons encountering health services for examination and investigation

316

578

2.75

50.22

1.6

1.21

1.26

nmol/l

0.30

226

478

Intracranial trauma

308

788

2.65

50.10

1.6

1.7

1.25

1.24

nmol/l

0.07

229

638

Other diseases of pancreas

177

5.49

48.62

1.5

1.3

0.95

1.22

nmol/l

1.34

126

Codeine

515

1326

2.11

47.55

1.6

1.26

1.30

nmol/l

0.27

388

1035

Implicit viral Sepsis, including avohilmo

206

683

3.03

47.22

1.5

1.32

1.21

nmol/l

0.60

146

511

Cardiovascular diseases

288

554

2.77

47.21

1.7

2.1

1.33

nmol/l

0.03

223

441

Influenza and pneumonia

586

1836

1.98

47.21

1.5

1.7

1.35

1.26

nmol/l

0.94

446

1405

All pneumoniae

569

1869

1.98

46.98

1.4

1.6

1.37

1.25

nmol/l

1.26

430

1432

Fitting and adjustment of other devices

242

770

2.79

46.27

1.4

1.3

1.17

1.26

nmol/l

0.60

184

554

Explicit Sepsis, including avohilmo

279

987

2.58

46.13

1.4

1.5

1.18

1.27

nmol/l

0.59

206

740

Explicit Sepsis

274

974

2.58

45.35

1.4

1.5

1.18

1.26

nmol/l

0.56

201

731

Abnormal findings on examination of blood, without diagnosis

322

1232

2.38

44.88

1.5

1.4

1.20

1.29

nmol/l

0.61

259

904

Pneumonias (Asthma/COPD co-morbidities)

560

1872

1.96

44.75

1.4

1.6

1.38

1.25

nmol/l

1.32

423

1433

Hypertensive heart and/or renal disease

152

300

3.73

44.11

1.3

1.12

1.25

nmol/l

0.63

226

Peripheral artery disease

286

899

2.53

44.08

1.3

1.16

1.23

nmol/l

0.44

205

670

Hard cardiovascular diseases

470

1340

2.08

43.12

1.5

1.24

nmol/l

0.01

366

999

Cerebrovascular diseases (FINNGEN)

164

332

3.48

42.68

1.5

1.18

1.29

nmol/l

0.51

129

255

Diseases of liver

246

951

2.61

42.50

1.4

1.34

1.22

nmol/l

0.79

181

710

492

1419

2.03

42.42

1.4

1.6

1.33

1.24

nmol/l

0.75

367

1087

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

492

1419

2.03

42.42

1.4

1.6

1.33

1.24

nmol/l

0.75

367

1087

Episodal and paroxysmal disorders

551

1427

1.96

41.67

1.7

1.6

1.36

1.22

nmol/l

1.87

405

1128

Codeine or tramadol medication

606

1750

1.89

41.51

1.6

1.29

1.27

nmol/l

0.10

456

1343

Care involving use of rehabilitation procedures

367

1526

2.17

41.29

1.5

1.6

1.25

1.29

nmol/l

0.27

315

1144

Ischemic heart diseases

469

1370

2.05

41.29

1.5

1.4

1.20

1.26

nmol/l

0.43

354

1024

Diabetes mellitus in pregnancy

176

339

3.32

41.29

2.3

2.1

1.40

1.38

nmol/l

0.07

150

270

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

543

1893

1.92

40.88

1.4

1.6

1.38

1.25

nmol/l

1.44

411

1450

Mood disorders, excluding more controls

501

1484

1.99

40.85

1.6

1.33

1.26

nmol/l

0.54

365

1147

Tramadol

431

1245

2.09

40.21

1.5

1.6

1.33

1.29

nmol/l

0.30

306

969

Hypertensive Heart Disease

138

285

3.70

40.17

1.3

1.10

1.24

nmol/l

0.63

211

Secondary hypertension

105

6.38

40.08

1.5

1.3

1.38

1.28

nmol/l

0.21

Septicaemia

265

986

2.47

40.04

1.4

1.14

1.27

nmol/l

1.08

192

735

Other septicaemia, including avohilmo

245

909

2.55

39.86

1.4

1.14

1.26

nmol/l

0.91

179

678

Chronic periodontitis, complicated

352

1595

2.16

39.74

1.4

1.5

1.33

1.26

nmol/l

0.44

250

1213

Other septicaemia

241

897

2.55

39.38

1.4

1.14

1.26

nmol/l

0.94

175

671

Neurological diseases

404

940

2.17

39.25

1.8

1.7

1.34

1.23

nmol/l

0.98

300

754

Major coronary heart disease event

469

1405

2.01

39.17

1.5

1.4

1.23

1.24

nmol/l

0.05

357

1046

Percutaneous Coronary Intervention

443

1327

2.04

38.86

1.5

1.4

1.20

1.26

nmol/l

0.42

342

992

Coronary revascularization (ANGIO or CABG)

443

1328

2.04

38.65

1.5

1.4

1.20

1.26

nmol/l

0.45

342

993

Glomerular diseases

143

433

3.34

38.51

1.6

1.4

1.31

1.21

nmol/l

0.36

323

Erysipelas, including avohilmo

414

1504

2.05

38.49

1.5

1.30

1.28

nmol/l

0.10

302

1144

Caries of dentine

154

470

3.19

38.15

1.6

1.5

1.41

1.19

nmol/l

1.16

108

362

Other and unspecified iron deficiency

212

803

2.65

38.02

1.7

1.5

1.36

1.25

nmol/l

0.46

159

604

Presence of other devices

162

523

3.07

37.97

1.4

1.3

1.10

1.29

nmol/l

1.48

129

397

Gestational diabetes (for exclusion)

189

445

2.94

37.40

2.6

2.0

1.47

1.37

nmol/l

0.49

165

348

Disorders of lens

373

1087

2.14

37.20

1.4

1.23

1.33

nmol/l

0.70

265

836

Gastro-oesophageal reflux disease

383

1577

2.06

37.03

1.6

1.5

1.28

1.30

nmol/l

0.09

273

1196

Dental caries

165

525

2.99

36.50

1.6

1.5

1.40

1.22

nmol/l

0.91

117

405

Nutritional anaemias

288

1218

2.27

36.39

1.6

1.5

1.33

1.24

nmol/l

0.52

217

915

Bacterial infection, other or unspecified, including avohilmo

330

1257

2.16

36.06

1.4

1.5

1.19

1.30

nmol/l

0.92

242

948

Iron deficiency anaemia

252

1042

2.39

36.06

1.6

1.5

1.37

1.24

nmol/l

0.78

186

779

Mood disorders

548

1914

1.84

36.00

1.7

1.6

1.35

1.26

nmol/l

0.89

398

1482

Pneumonia, organism unspecified

488

1770

1.90

35.96

1.4

1.6

1.35

1.25

nmol/l

0.92

362

1350

Other functional intestinal disorders

268

1050

2.33

35.85

1.5

1.6

1.20

1.30

nmol/l

0.72

215

800

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

200

452

2.80

35.51

1.5

1.9

1.27

1.31

nmol/l

0.18

143

352

Mood [affective] disorders

545

1914

1.83

35.40

1.6

1.35

1.26

nmol/l

0.99

397

1482

Malignant neoplasm of pancreas, including Hilmo

198

4.47

35.27

1.3

0.97

1.24

nmol/l

2.15

138

Other soft tissue disorders, not elsewhere classified

483

1437

1.92

35.25

1.6

1.17

1.32

nmol/l

2.06

356

1109

Sleep disorders (combined)

555

1579

1.84

35.08

1.6

1.35

1.22

nmol/l

1.76

389

1244

Amputation

220

4.25

34.95

1.5

1.4

1.08

1.19

nmol/l

0.40

157

Emergency coronary revascularization (for ACS)

463

1455

1.93

34.82

1.5

1.4

1.18

1.24

nmol/l

0.47

355

1084

Pain in throat and chest

435

1312

1.97

34.60

1.6

1.32

1.22

nmol/l

0.86

337

1006

Opioids

491

1333

1.91

34.46

1.7

1.6

1.29

1.30

nmol/l

0.05

367

1041

Infections of the skin and subcutaneous tissue

347

1669

2.06

34.46

1.6

1.20

1.25

nmol/l

0.33

242

1291

Atrial fibrillation and flutter

156

319

3.17

34.42

1.5

1.20

1.27

nmol/l

0.33

123

242

Depression

505

1830

1.85

34.37

1.7

1.6

1.34

1.26

nmol/l

0.83

366

1421

Senile cataract

337

954

2.16

34.27

1.4

1.24

1.32

nmol/l

0.50

241

731

Other disorders of skin and subcutaneous tissue, not elsewhere classified

115

327

3.56

34.22

1.5

1.4

1.16

1.28

nmol/l

0.47

238

Malignant neoplasm of pancreas

160

4.84

33.93

1.3

0.97

1.26

nmol/l

1.99

114

Other and unspecified polyneuropathies, also in other diseases

143

470

3.08

33.67

1.3

1.25

1.23

nmol/l

0.06

352

Presence of cardiac and vascular implants and grafts

254

796

2.36

33.38

1.3

1.34

1.26

nmol/l

0.37

184

596

Dyspnoea

480

1875

1.85

33.38

1.6

1.5

1.45

1.25

nmol/l

2.21

351

1435

Acidosis

11.02

33.29

1.4

1.21

1.09

nmol/l

0.24

Peripheral arterial reconstruction

123

377

3.30

32.55

1.4

1.3

1.18

nmol/l

0.01

275

Other intervertebral disc disorders

446

1400

1.91

32.39

1.6

1.22

1.30

nmol/l

0.85

343

1070

Ischaemic heart disease, wide definition

413

1310

1.95

32.19

1.4

1.23

1.25

nmol/l

0.09

307

978

General symptoms and signs

540

1497

1.81

32.18

1.6

1.26

1.27

nmol/l

0.02

408

1158

Carpal tunnel syndrome

323

1372

2.05

31.16

1.6

1.5

1.23

1.31

nmol/l

0.67

237

1039

Erysipelas

318

1339

2.06

30.97

1.4

1.28

nmol/l

0.03

229

1015

Alcohol-induced acute pancreatitis

6.49

30.92

1.4

1.5

0.89

1.24

nmol/l

1.45

Heart failure,strict

282

903

2.19

30.84

1.4

1.3

1.48

1.18

nmol/l

2.18

194

670

Symptoms and signs involving the circulatory and respiratory systems

488

1329

1.85

30.82

1.7

1.6

1.33

1.23

nmol/l

0.88

371

1022

Polyneuropathies and other disorders of the peripheral nervous system

151

538

2.83

30.79

1.3

1.4

1.26

1.22

nmol/l

0.10

403

Atrial fibrillation and flutter with reimbursement

130

248

3.32

30.62

1.3

1.18

1.31

nmol/l

0.73

100

183

Atherosclerosis, excluding cerebral and coronary sclerosis

244

840

2.30

30.62

1.3

1.20

1.22

nmol/l

0.05

176

631

Pain in limb

421

1417

1.89

30.50

1.6

1.17

1.32

nmol/l

1.93

306

1095

Major coronary heart disease event excluding revascularizations

330

1066

2.05

30.20

1.3

1.32

1.21

nmol/l

0.78

250

772

Symptoms and signs involving the digestive system and abdomen

503

1394

1.81

30.10

1.6

1.5

1.23

1.29

nmol/l

0.58

366

1061

Other diseases of intestines

535

1693

1.77

30.08

1.6

1.20

1.31

nmol/l

1.31

401

1296

Bacterial infection, other or unspecified

295

1195

2.09

29.97

1.4

1.5

1.21

1.29

nmol/l

0.56

215

897

Oxycodone

231

861

2.31

29.89

1.3

1.4

1.22

1.30

nmol/l

0.50

172

655

Peripheral artery operations in Hilmo

265

3.66

29.88

1.5

1.3

1.27

1.23

nmol/l

0.09

195

Missing teeth due to accident, extraction or parodontitis

347

1587

1.96

29.83

1.5

1.4

1.33

1.25

nmol/l

0.61

256

1193

Obesity related asthma

221

961

2.32

29.74

1.6

1.44

1.24

nmol/l

1.78

167

719

Chronic apical periodontitis

560

1818

1.73

29.56

1.7

1.6

1.29

1.27

nmol/l

0.07

419

1397

Cholelithiasis, broad definition with cholecystitis

425

1524

1.86

29.55

1.7

1.5

1.28

1.32

nmol/l

0.30

347

1125

Mouth breathing

243

1101

2.22

29.51

1.4

1.5

1.39

1.24

nmol/l

1.24

193

814

Complications of surgical and medical care, not elsewhere classified

517

1979

1.75

29.26

1.6

1.24

1.30

nmol/l

0.38

384

1517

Diseases of arteries, arterioles and capillaries

364

1382

1.94

29.18

1.4

1.20

1.26

nmol/l

0.46

266

1030

Any mental disorder

528

1502

1.77

28.97

1.6

1.20

1.27

nmol/l

0.69

390

1161

Ulcer of lower limb, not elsewhere classified

109

335

3.29

28.79

1.4

1.3

1.05

1.23

nmol/l

0.89

236

Other antidepressants

509

1467

1.78

28.64

1.5

1.29

1.26

nmol/l

0.23

371

1156

Care involving dialysis

171

4.34

28.60

1.8

1.5

1.33

nmol/l

0.01

125

Depression or dysthymia

332

895

2.03

28.36

1.6

1.5

1.20

1.23

nmol/l

0.13

240

703

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

117

380

3.12

28.23

1.4

1.3

1.22

1.18

nmol/l

0.18

284

Anxiety disorders, excluding more controls

401

1372

1.87

28.19

1.6

1.28

1.27

nmol/l

0.05

289

1061

Coronary atherosclerosis

344

1104

1.97

28.07

1.4

1.20

1.25

nmol/l

0.27

254

812

Familial hypercholesterolemia

101

304

3.36

27.59

1.3

1.06

1.21

nmol/l

0.65

223

Dialysis, with operation codes

276

3.48

27.46

1.7

1.4

1.25

1.22

nmol/l

0.05

199

Abdominal and pelvic pain

491

1394

1.77

27.42

1.6

1.5

1.19

1.29

nmol/l

1.03

366

1061

Acute tubulo-interstitial nephritis

315

1354

1.97

27.27

1.5

1.6

1.24

1.27

nmol/l

0.13

242

1031

Cholelithiasis

402

1497

1.84

27.08

1.7

1.5

1.30

1.32

nmol/l

0.13

326

1103

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

328

1680

1.92

27.07

1.5

1.21

1.28

nmol/l

0.52

244

1267

Hernia of abdominal wall, postoperative

118

391

3.02

27.07

1.7

1.3

1.37

1.32

nmol/l

0.15

298

Substance abuse, excluding more controls

298

1249

2.00

26.91

1.5

1.6

1.18

1.27

nmol/l

0.71

219

969

Cirrhosis of liver, NAS

127

4.83

26.71

1.4

1.27

1.14

nmol/l

0.45

Fall on same level

565

1795

1.68

26.63

1.6

1.21

1.31

nmol/l

1.35

412

1404

Nausea and vomiting

152

570

2.62

26.60

1.4

1.5

1.32

1.29

nmol/l

0.13

112

433

Nonalcoholic fatty liver disease

236

3.65

26.34

1.4

1.72

1.25

nmol/l

1.78

174

Diabetic nephropathy, excluding more controls

220

811

2.25

26.19

1.6

1.5

1.03

1.36

nmol/l

4.34

163

608

Fibrosis and cirrhosis of liver

167

4.20

25.93

1.4

1.26

1.08

nmol/l

0.80

121

Recurrent or chronic depression

201

600

2.33

25.62

1.7

1.49

1.23

nmol/l

2.15

141

471

Cellulitis

144

552

2.63

25.56

1.5

1.19

1.29

nmol/l

0.44

415

Headache

332

1353

1.90

25.51

1.8

1.6

1.39

1.26

nmol/l

1.11

252

1041

All influenza

155

617

2.53

25.43

1.5

1.6

1.39

1.22

nmol/l

1.06

122

454

Other disorders of skin and subcutaneous tissue

376

1753

1.82

25.42

1.5

1.19

1.30

nmol/l

1.12

289

1313

Amputation of toe

157

4.28

25.39

1.6

1.4

1.04

nmol/l

0.01

107

Other diseases of liver

122

433

2.84

25.16

1.4

1.53

1.23

nmol/l

1.37

323

Complications of medical and surgical care

378

1893

1.80

25.09

1.5

1.6

1.23

1.30

nmol/l

0.50

277

1435

Diabetic retinopathy, strict definition

272

1218

2.02

24.92

1.5

0.85

1.27

nmol/l

6.64

180

931

Follow-up examination after treatment for conditions other than malignant neoplasms

175

474

2.47

24.92

1.8

1.6

1.24

1.27

nmol/l

0.09

123

403

Shoulder lesions

385

1267

1.83

24.76

1.5

1.25

1.30

nmol/l

0.36

291

971

Other dorsopathies, not elsewhere classified

487

1477

1.72

24.63

1.6

1.22

1.31

nmol/l

1.10

374

1134

Other and unspecified nerve root and plexus disorders, also in other diseases

132

494

2.69

24.60

1.3

1.5

1.33

1.30

nmol/l

0.13

104

367

Any gastric operation

335

870

1.94

24.60

1.8

1.5

1.29

1.32

nmol/l

0.11

247

687

GASTRO-related operations

335

870

1.94

24.60

1.8

1.5

1.29

1.32

nmol/l

0.11

247

687

Diabetic retinopathy, excluding more controls

349

1046

1.89

24.19

1.4

1.5

0.97

1.38

nmol/l

7.60

235

784

Pure hyperglyceridaemia

8.63

24.12

1.8

1.4

1.41

1.03

nmol/l

0.55

Selective serotonin reuptake inhibitors

482

1468

1.71

24.11

1.7

1.5

1.26

nmol/l

0.06

348

1157

Complications of procedures, not elsewhere classified

414

1923

1.74

24.02

1.7

1.6

1.23

1.30

nmol/l

0.53

314

1467

Other symptoms and signs involving the nervous and musculoskeletal systems

228

1097

2.09

23.94

1.7

1.6

1.22

1.26

nmol/l

0.23

192

822

Myocardial infarction

261

899

2.04

23.92

1.4

1.3

1.36

1.22

nmol/l

0.79

199

648

Familial hypercholesterolemia, with ischemic heart disease

169

4.02

23.83

1.2

1.3

1.06

1.10

nmol/l

0.11

121

Presence of other functional implants

295

1040

1.95

23.81

1.4

1.02

1.28

nmol/l

3.27

189

791

Factors influencing health status and contact with health services

133

230

2.91

23.68

1.5

1.33

1.18

nmol/l

0.71

101

189

Symptoms and signs involving cognition, perception, emotional state and behaviour

483

1931

1.68

23.65

1.5

1.6

1.24

1.29

nmol/l

0.38

354

1484

Transplanted organ and tissue status

207

3.67

23.48

1.9

1.4

1.18

1.21

nmol/l

0.07

154

Psychiatric diseases

459

1337

1.72

23.38

1.5

1.6

1.21

1.27

nmol/l

0.45

340

1044

Alcohol use disorder, Swedish definition

304

1476

1.88

23.25

1.5

1.13

1.29

nmol/l

1.98

224

1128

All-cause Heart Failure

304

1111

1.91

23.23

1.4

1.3

1.47

1.20

nmol/l

2.20

216

821

317

1535

1.85

23.06

1.4

1.5

1.13

1.30

nmol/l

1.76

235

1176

Heart failure, strict

306

1124

1.90

22.98

1.3

1.47

1.20

nmol/l

2.22

216

833

Myocardial infarction, strict

244

844

2.06

22.98

1.4

1.3

1.39

1.21

nmol/l

1.01

185

603

Dorsalgia

471

1477

1.69

22.85

1.6

1.19

1.31

nmol/l

1.62

350

1134

Diseases of pulp and periapical tissues, including avohilmo

472

1444

1.69

22.80

1.7

1.5

1.32

1.28

nmol/l

0.30

346

1099

327

1562

1.83

22.74

1.5

1.15

1.30

nmol/l

1.52

244

1196

Certain infectious and parasitic diseases

449

1313

1.72

22.58

1.6

1.20

1.31

nmol/l

1.07

330

1028

Other cataract

222

791

2.09

22.24

1.4

1.34

1.35

nmol/l

0.03

147

606

Angina pectoris

284

980

1.93

22.16

1.3

1.29

1.24

nmol/l

0.24

225

713

Other disorders of urethra and urinary system

336

1290

1.82

22.06

1.6

1.34

1.27

nmol/l

0.51

244

992

Polycystic ovarian syndrome, consortium definition

302

911

1.91

22.03

1.9

1.8

1.36

1.34

nmol/l

0.08

224

713

Other heart diseases, wide

442

1590

1.69

21.78

1.6

1.7

1.28

1.27

nmol/l

0.03

340

1215

Functional dyspepsia

148

621

2.40

21.76

1.9

1.6

1.33

1.28

nmol/l

0.19

123

485

Covid-19 confirmed case

202

963

2.11

21.72

1.5

1.19

1.23

nmol/l

0.19

155

716

Disorders of other endocrine glands

228

1119

2.01

21.70

1.7

1.72

1.18

nmol/l

6.19

179

848

Periodontitis

491

1921

1.63

21.63

1.5

1.6

1.32

1.26

nmol/l

0.53

360

1472

Cutaneous abscess, furuncle and carbuncle

156

672

2.34

21.63

1.8

1.6

1.14

1.32

nmol/l

1.13

115

515

Unspecified urinary incontinence

182

3.73

21.51

1.6

1.4

1.46

1.24

nmol/l

0.54

133

Chronic periodontitis, including avohilmo

490

1922

1.63

21.48

1.5

1.6

1.33

1.26

nmol/l

0.59

359

1473

Diseases of the ear and mastoid process

546

1709

1.60

21.30

1.7

1.6

1.25

1.29

nmol/l

0.36

415

1322

ILD medications: prednisolone, methylprednisolone, prednisone

523

1807

1.61

21.30

1.6

1.33

1.26

nmol/l

0.70

389

1398

Vitreous haemorrhage

237

3.33

21.13

1.7

1.4

1.00

1.24

nmol/l

0.61

174

Other CVD (FINNGEN)

124

3.97

20.75

1.4

1.3

1.12

1.31

nmol/l

0.67

Parasetamol

314

855

1.86

20.68

1.7

1.6

1.32

1.20

nmol/l

0.91

226

656

Malaise and fatigue

257

1057

1.92

20.55

1.6

1.33

1.24

nmol/l

0.52

191

802

Oedema, not elsewhere classified

172

769

2.20

20.53

1.3

1.5

1.28

1.20

nmol/l

0.37

119

580

Soft tissue disorders

465

1444

1.65

20.52

1.7

1.6

1.19

1.32

nmol/l

1.48

362

1114

Pain in joint

282

918

1.89

20.50

1.9

1.5

1.41

1.27

nmol/l

0.90

217

706

Aplastic and other anaemias

241

1145

1.93

20.21

1.4

1.40

1.23

nmol/l

0.94

178

848

ILD medications

534

1819

1.59

20.20

1.7

1.6

1.30

1.26

nmol/l

0.28

399

1408

Moderate visual impairment, binocular

6.88

20.02

1.3

1.4

0.79

0.92

nmol/l

0.37

Charcot foot

17.00

19.79

1.8

1.4

1.35

1.56

nmol/l

0.22

Other dialysis

5.98

19.71

2.2

1.5

1.06

1.18

nmol/l

0.18

Intestinal malabsorption

109

4.49

19.68

1.9

1.5

0.91

1.31

nmol/l

1.59

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

288

1603

1.80

19.55

1.6

1.5

1.15

1.27

nmol/l

0.94

213

1200

Injuries to the head

528

2002

1.57

19.47

1.6

1.21

1.29

nmol/l

0.84

392

1540

Benzodiazepine use

484

2058

1.59

19.47

1.6

1.32

1.27

nmol/l

0.41

349

1593

Persons encountering health services in other circumstances, wide

541

1776

1.57

19.41

1.7

1.5

1.32

1.26

nmol/l

0.52

403

1353

Symptoms and signs involving the urinary system

378

1701

1.68

19.29

1.5

1.29

1.27

nmol/l

0.12

264

1301

Redundant prepuce, phimosis and paraphimosis

139

590

2.34

19.23

1.4

1.5

1.12

1.18

nmol/l

0.41

102

452

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

163

351

2.34

19.22

1.6

1.34

1.22

nmol/l

0.63

127

265

Cholecystectomy

336

1663

1.72

19.09

1.8

1.5

1.28

nmol/l

0.01

280

1225

COPD/asthma/ILD related infections

460

1419

1.63

19.06

1.6

1.28

1.24

nmol/l

0.25

354

1087

COPD/asthma related infections

460

1419

1.63

19.06

1.6

1.28

1.24

nmol/l

0.25

354

1087

Lumbar disc prolapse

318

1344

1.76

19.00

1.5

1.6

1.28

1.30

nmol/l

0.15

249

1031

Low back pain

366

1459

1.70

19.00

1.5

1.6

1.24

1.32

nmol/l

0.62

275

1120

Myocardial infarction, without ST-elevation

212

973

1.98

18.89

1.3

1.35

1.21

nmol/l

0.72

156

717

Asthma, excluding more controls

334

974

1.76

18.70

1.7

1.6

1.27

1.22

nmol/l

0.30

260

766

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

138

593

2.31

18.69

1.4

1.8

1.15

1.30

nmol/l

0.91

469

Lower back pain or/and sciatica

512

2047

1.56

18.57

1.5

1.6

1.24

1.30

nmol/l

0.53

385

1567

Personality disorders, excluding more controls

134

578

2.33

18.48

1.5

1.9

1.27

1.28

nmol/l

0.05

100

457

Anxiety disorders

428

1823

1.61

18.39

1.7

1.6

1.29

1.28

nmol/l

0.03

308

1412

Intracranial injury

292

1548

1.76

18.38

1.6

1.27

nmol/l

0.03

213

1179

Neurotic, stress-related and somatoform disorders

424

1810

1.62

18.37

1.7

1.6

1.29

1.28

nmol/l

0.05

305

1400

Asthma, unspecified (mode), excluding more controls

242

916

1.90

18.35

1.5

1.7

1.37

1.23

nmol/l

1.02

184

720

Diseases of the eye and adnexa

353

1029

1.72

18.12

1.7

1.26

1.38

nmol/l

0.94

262

834

Other pulmonary diagnosis

361

1061

1.71

18.01

1.6

1.29

1.24

nmol/l

0.35

274

825

L04AD Calcineurin inhibitors

257

3.03

17.90

1.9

1.5

1.19

1.22

nmol/l

0.09

189

Poisoning by drugs, medicaments and biological substances

129

557

2.33

17.89

1.5

1.8

1.07

1.35

nmol/l

2.21

421

Poisoning by medicine

119

497

2.41

17.79

1.5

1.7

1.09

1.36

nmol/l

1.98

373

Disorder of lipoprotein metabolism, unspecified

263

2.99

17.79

1.3

1.13

1.23

nmol/l

0.30

189

Bleeding

400

1729

1.63

17.79

1.5

1.19

1.28

nmol/l

0.65

289

1312

Persons encountering health services in other circumstances

203

1037

1.94

17.63

1.6

1.33

1.21

nmol/l

0.70

160

795

Heart failure and coronary heart disease

209

747

1.97

17.58

1.3

1.48

1.18

nmol/l

1.77

148

529

Excluding asthma or asthma-COPD overlap

359

1061

1.70

17.57

1.5

1.6

1.28

1.24

nmol/l

0.25

270

825

Polycystic ovarian syndrome

4.93

17.57

2.7

2.4

1.91

1.41

nmol/l

1.10

Other and unspecified anaemias

217

1074

1.90

17.54

1.4

1.38

1.22

nmol/l

0.86

162

793

Other anaemias

218

1079

1.90

17.46

1.4

1.38

1.21

nmol/l

0.88

162

797

Drug-induced hypoglycaemia without coma

14.40

17.43

1.3

1.6

0.76

0.99

nmol/l

0.48

Hyperkalaemia

107

4.26

17.40

1.4

1.46

1.10

nmol/l

0.61

Mixed hyperlipidaemia

5.02

17.39

1.2

1.3

1.22

1.17

nmol/l

0.08

Substance abuse

298

1613

1.72

17.28

1.5

1.6

1.18

1.28

nmol/l

0.75

219

1239

Mental and behavioural disorders due to psychoactive substance use

304

1631

1.71

17.25

1.5

1.6

1.16

1.28

nmol/l

1.02

225

1254

Diseases of the digestive system

229

1230

1.85

17.24

1.6

1.5

1.15

1.25

nmol/l

0.70

172

911

Falls/tendency to fall

481

1540

1.57

17.18

1.5

1.7

1.19

1.31

nmol/l

1.46

353

1209

Viral pneumonia

281

2.87

16.98

1.5

1.4

1.29

1.17

nmol/l

0.39

202

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

323

1677

1.68

16.97

1.5

1.34

1.25

nmol/l

0.67

253

1248

Extreme obesity with alveolar hypoventilation

4.68

16.85

1.1

1.5

1.92

1.22

nmol/l

2.27

Chronic ulcer of skin, not elsewhere classified

155

3.60

16.82

1.6

1.3

1.12

1.20

nmol/l

0.17

111

Impingement syndrome of shoulder

133

598

2.24

16.80

1.4

1.40

1.26

nmol/l

0.59

439

Asthma

344

1050

1.69

16.78

1.7

1.6

1.26

1.24

nmol/l

0.11

269

815

Fever of other and unknown origin

263

1289

1.77

16.72

1.5

1.32

1.25

nmol/l

0.45

196

987

Symptoms and signs involving the nervous and musculoskeletal systems

280

1624

1.73

16.71

1.6

1.5

1.21

1.27

nmol/l

0.37

231

1206

Diarrhoea and gastroenteritis of presumed infectious origin

336

1820

1.65

16.64

1.5

1.6

1.22

1.28

nmol/l

0.45

248

1400

Diseases of the skin and subcutaneous tissue

446

1418

1.58

16.57

1.6

1.17

1.30

nmol/l

1.38

327

1107

Asthma, unspecified (mode)

248

988

1.82

16.56

1.5

1.6

1.36

1.25

nmol/l

0.72

189

767

Nephropathy related operations

286

2.83

16.47

1.8

1.4

1.23

1.22

nmol/l

0.03

208

Bacterial pneumoniae

198

906

1.93

16.42

1.4

1.5

1.39

1.23

nmol/l

0.80

164

674

Intestinal infectious diseases

438

2098

1.55

16.39

1.6

1.21

1.30

nmol/l

0.92

321

1614

Other/unspecified dorsalgia

185

939

1.95

16.33

1.7

1.6

1.26

1.27

nmol/l

0.01

141

706

Dental pulpitis, including avohilmo

429

1755

1.57

16.24

1.7

1.6

1.31

1.28

nmol/l

0.18

331

1346

Pain, not elsewhere classified

142

666

2.14

16.15

1.6

1.30

1.24

nmol/l

0.22

101

504

Bacterial pneumonia, not elsewhere classified

187

846

1.95

16.06

1.4

1.5

1.42

1.23

nmol/l

0.97

159

631

COPD differential diagnosis

353

1066

1.66

16.02

1.5

1.6

1.28

1.24

nmol/l

0.28

269

825

Genitourinary diseases

267

745

1.80

16.02

1.6

1.20

1.23

nmol/l

0.14

197

566

ILD differential diagnosis

353

1066

1.66

16.02

1.5

1.6

1.28

1.24

nmol/l

0.28

269

825

Arthropathies in other diseases classified elsewhere

4.77

15.92

1.8

1.2

1.30

1.19

nmol/l

0.15

Anaemia in chronic diseases classified elsewhere

6.49

15.89

1.3

1.4

1.40

1.13

nmol/l

0.33

Substance use, excluding alcohol

113

488

2.33

15.74

1.5

1.7

1.11

1.30

nmol/l

1.05

366

Iron deficiency

6.96

15.72

2.0

1.8

1.93

1.04

nmol/l

1.12

Hypothyroidism, strict autoimmune

305

1185

1.69

15.72

1.8

1.6

1.23

1.42

nmol/l

1.88

225

913

Oral corticosteroids

493

1912

1.51

15.68

1.6

1.33

1.26

nmol/l

0.59

373

1465

Other symptoms and signs involving cognitive functions and awareness

234

1159

1.80

15.64

1.5

1.4

1.17

1.24

nmol/l

0.40

170

870

133

527

2.18

15.35

1.4

1.3

1.16

1.28

nmol/l

0.40

392

Inflammatory bowel disease treatment related agents

521

1940

1.49

15.29

1.6

1.32

1.26

nmol/l

0.48

391

1488

Alcoholic liver disease

238

2.93

15.20

1.4

1.3

1.17

1.15

nmol/l

0.04

178

Necrosis of pulp, including avohilmo

289

1716

1.67

15.16

1.7

1.6

1.32

1.26

nmol/l

0.32

226

1306

Heart failure and bmi 25plus

203

721

1.89

15.02

1.4

1.60

1.34

nmol/l

1.14

130

521

Kidney transplant status

107

3.98

14.88

2.4

1.4

1.07

1.33

nmol/l

0.54

Visual disturbances and blindness

248

1438

1.73

14.85

1.5

1.6

1.17

1.24

nmol/l

0.43

175

1088

Hypo-osmolality and hyponatraemia

357

2.52

14.84

1.3

1.26

1.25

nmol/l

0.03

261

Oesophageal varices

4.30

14.84

1.4

1.30

1.12

nmol/l

0.41

Other specific joint derangements/joint disorders

344

1327

1.62

14.82

1.9

1.6

1.34

1.22

nmol/l

0.84

262

1028

First line medication for Crohn's disease

493

1772

1.50

14.74

1.6

1.25

1.26

nmol/l

0.06

378

1363

Hypokalaemia

237

2.89

14.70

1.7

1.4

1.25

1.26

nmol/l

0.02

170

Dorsopathies

447

1479

1.53

14.64

1.6

1.19

1.31

nmol/l

1.55

342

1136

Persons encountering health services for other counselling and medical advice, not elsewhere classified

497

1774

1.49

14.44

1.8

1.5

1.32

1.26

nmol/l

0.45

381

1351

Sciatica+with lumbago

246

1266

1.73

14.39

1.6

1.30

nmol/l

0.01

188

968

Anxiety (asthma-related co-morbidities)

267

1198

1.70

14.37

1.7

1.40

1.26

nmol/l

1.07

189

941

Ascites

157

3.35

14.35

1.2

1.4

1.31

1.26

nmol/l

0.13

117

Osteomyelitis

138

3.52

14.30

1.5

1.4

1.17

1.27

nmol/l

0.21

Asthma (mode)

331

1066

1.63

14.30

1.6

1.29

1.24

nmol/l

0.30

260

825

Diabetic nephropathy

220

1238

1.78

14.27

1.6

1.4

1.03

1.24

nmol/l

2.25

163

918

Menorrhagia

144

379

2.13

14.22

1.9

1.7

1.26

1.27

nmol/l

0.01

103

292

Other diseases of urinary system

437

1616

1.52

14.12

1.6

1.34

1.26

nmol/l

0.62

333

1240

Gastrointestinal diseases

230

638

1.81

14.10

1.7

1.6

1.33

1.32

nmol/l

0.04

170

505

Suicide or other Intentional self-harm

125

591

2.13

14.01

1.4

1.7

1.12

1.32

nmol/l

1.38

452

Gout

151

651

2.00

13.98

1.3

1.59

1.19

nmol/l

3.77

107

485

Exclusions for E4_PCOS_BROAD

395

2.39

13.95

1.7

1.6

1.72

1.27

nmol/l

2.06

292

Preparatory care for dialysis

4.01

13.91

1.9

1.4

1.49

1.16

nmol/l

0.60

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

360

2.46

13.89

1.5

1.8

1.08

1.37

nmol/l

1.77

275

Bacterial pneumonia (organism specified)

211

1076

1.78

13.86

1.4

1.5

1.38

1.24

nmol/l

0.72

173

795

Gout, unspecified

114

525

2.19

13.69

1.3

1.62

1.11

nmol/l

4.23

383

Personality disorders

134

663

2.03

13.33

1.5

1.9

1.27

1.30

nmol/l

0.12

100

508

Dialysis

4.63

13.32

2.8

1.5

0.99

1.17

nmol/l

0.32

Other disorders of ear

416

1787

1.51

13.29

1.6

1.5

1.18

1.29

nmol/l

1.12

319

1354

Injuries to the knee and lower leg

527

1974

1.45

13.20

1.6

1.26

1.30

nmol/l

0.29

383

1525

Diseases of oral cavity, salivary glands and jaws

245

730

1.73

13.12

1.4

1.5

1.23

1.24

nmol/l

0.02

176

560

Disorders of adult personality and behaviour

141

715

1.98

13.10

1.5

1.9

1.26

1.29

nmol/l

0.14

105

552

Sensorineural hearing loss

341

1458

1.56

12.92

1.5

1.4

1.14

1.29

nmol/l

1.47

259

1091

Ovarian dysfunction

123

3.53

12.92

2.8

2.2

1.98

1.39

nmol/l

1.72

Pain associated with micturition

266

2.65

12.91

1.6

1.4

1.14

1.21

nmol/l

0.22

197

Examination and observation for other reasons

189

577

1.85

12.86

1.7

1.6

1.31

1.26

nmol/l

0.19

130

477

Hyperlipidaemia, other/unspecified

173

844

1.85

12.85

1.3

1.31

1.22

nmol/l

0.39

109

621

Dizziness and giddiness

333

1666

1.56

12.80

1.5

1.27

1.29

nmol/l

0.12

254

1270

Disorders of synovium and tendon

241

1220

1.68

12.77

1.7

1.6

1.36

1.30

nmol/l

0.26

179

941

Other headache syndromes

174

950

1.83

12.77

1.9

1.7

1.26

1.20

nmol/l

0.30

128

751

Conductive and sensorineural hearing loss

356

1535

1.54

12.76

1.5

1.4

1.18

1.29

nmol/l

1.02

270

1149

Rotator cuff syndrome

281

1193

1.63

12.65

1.5

1.4

1.24

1.30

nmol/l

0.41

219

913

Polyarthropathies

306

1235

1.59

12.58

1.5

1.6

1.48

1.21

nmol/l

2.85

225

952

Pregnancy hypertension

166

801

1.86

12.54

2.2

1.8

1.54

1.31

nmol/l

1.48

132

621

Adenocarcinoma and ductal carcinoma of pancreas

4.28

12.48

1.2

1.4

0.96

1.11

nmol/l

0.51

Diabetic retinopathy

425

1788

1.49

12.48

1.4

0.97

1.32

nmol/l

7.91

286

1367

Constipation

397

1799

1.50

12.46

1.4

1.6

1.24

1.29

nmol/l

0.37

293

1363

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

138

708

1.96

12.43

1.4

1.9

1.15

1.33

nmol/l

1.28

552

Other maternal disorders predominantly related to pregnancy

208

740

1.76

12.38

2.0

1.7

1.39

1.36

nmol/l

0.10

172

560

Bronchitis

482

2003

1.45

12.38

1.7

1.6

1.33

1.27

nmol/l

0.38

365

1527

Specific personality disorders

114

547

2.09

12.36

1.5

1.8

1.29

1.30

nmol/l

0.03

414

Extracorporeal dialysis

132

3.38

12.33

2.0

1.5

1.27

1.16

nmol/l

0.19

100

Visual impairment including blindness (binocular or monocular)

152

3.19

12.32

1.2

1.3

1.15

1.13

nmol/l

0.04

108

Problems related to lifestyle

227

2.75

12.30

1.5

1.6

1.22

1.21

nmol/l

0.01

167

Gout, FINNGEN

151

798

1.89

12.20

1.3

1.59

1.13

nmol/l

4.88

107

597

Cervical disc disorders

171

947

1.81

12.17

1.5

1.4

1.18

1.29

nmol/l

0.60

125

717

Cerebrovascular diseases

334

1503

1.54

12.15

1.4

1.13

1.27

nmol/l

1.58

248

1124

Schizophrenia or delusion, excluding more controls

135

684

1.96

12.13

1.4

1.7

1.37

1.25

nmol/l

0.58

105

534

Gout, idiopatic and unspecified

130

660

1.98

12.09

1.3

1.64

1.13

nmol/l

4.84

491

Osteopathies and chondropathies

256

1444

1.62

12.08

1.6

1.5

1.16

1.28

nmol/l

1.07

192

1085

Early onset COPD, excluding more controls

103

480

2.15

12.03

1.4

1.32

1.20

nmol/l

0.44

356

Chronic gastritis

121

602

2.02

11.91

1.3

1.01

1.23

nmol/l

1.58

448

406

2.22

11.89

1.4

1.3

1.11

1.24

nmol/l

0.60

296

Amputation of thigh

5.43

11.84

1.4

1.5

1.07

1.16

nmol/l

0.15

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

178

866

1.79

11.84

2.2

1.8

1.57

1.33

nmol/l

1.68

142

669

Spinal stenosis

227

998

1.68

11.81

1.4

1.15

1.31

nmol/l

1.50

163

741

Impotence

141

3.23

11.79

1.4

1.3

1.05

1.22

nmol/l

0.55

104

Malignant neoplasm of digestive organs, including Hilmo

219

952

1.70

11.78

1.4

1.08

1.27

nmol/l

2.49

171

687

Other and unspecified disorders of skin and subcutaneous tissue

141

3.23

11.78

1.3

1.4

1.14

1.28

nmol/l

0.28

104

Somatoform disorder

370

2.31

11.76

1.6

1.35

1.37

nmol/l

0.04

271

Benign neoplasm: Colon

252

1466

1.62

11.75

1.5

1.3

1.29

1.26

nmol/l

0.13

179

1094

Other sleep disorders

216

2.75

11.73

1.3

1.4

1.08

1.15

nmol/l

0.24

159

Sequelae of injuries, of poisoning and of other consequences of external causes

123

620

1.99

11.69

1.8

1.5

1.10

1.28

nmol/l

1.16

465

Degeneration of macula and posterior pole

205

923

1.72

11.68

1.4

1.3

1.10

1.28

nmol/l

1.26

131

705

Benign neoplasms

429

1595

1.47

11.67

1.5

1.7

1.23

1.29

nmol/l

0.55

314

1234

Irritable bowel syndrome

125

635

1.98

11.61

1.9

1.7

1.25

1.28

nmol/l

0.12

494

Organic, including symptomatic, mental disorders

230

971

1.67

11.61

1.4

1.3

1.19

1.22

nmol/l

0.11

165

717

Benign neoplasm of colon, rectum, anus and anal canal

289

1565

1.56

11.55

1.4

1.27

1.26

nmol/l

0.03

208

1174

Disorders of mineral metabolism

169

2.98

11.51

1.9

1.4

1.28

1.19

nmol/l

0.23

120

Provisional assignment of new diseases of uncertain etiology

239

1463

1.62

11.44

1.6

1.23

1.24

nmol/l

0.07

184

1114

Asthma-related pneumonia

164

912

1.80

11.40

1.4

1.5

1.33

1.25

nmol/l

0.34

124

667

Asthma, hospital admissions 3, pneumonia

164

913

1.80

11.36

1.4

1.5

1.33

1.25

nmol/l

0.34

124

667

Asthma-related pneumonia or sepsis

164

913

1.80

11.36

1.4

1.5

1.33

1.25

nmol/l

0.34

124

667

Codes for special purposes

239

1466

1.62

11.34

1.6

1.23

1.24

nmol/l

0.06

184

1117

Diabetic maculopathy

177

958

1.77

11.31

1.3

1.5

0.76

1.27

nmol/l

10.99

112

738

Asthma-related infections

265

1639

1.58

11.29

1.6

1.34

1.26

nmol/l

0.50

206

1230

Asthma, hospital admission 2, infections

265

1639

1.58

11.29

1.6

1.34

1.26

nmol/l

0.50

206

1230

Phobic anxiety disorders

266

2.53

11.28

1.4

1.9

1.34

1.36

nmol/l

0.03

215

Paralytic ileus and intestinal obstruction

123

628

1.97

11.25

1.3

1.4

1.26

1.25

nmol/l

0.03

471

Status post-ami

124

474

1.99

11.22

1.4

1.3

1.62

1.19

nmol/l

1.82

340

Pain (limb, back, neck, head abdominally)

294

932

1.58

11.21

1.7

1.5

1.21

1.28

nmol/l

0.43

212

717

Neuralgia and neuritis, unspecified

101

3.61

11.19

2.0

1.4

1.34

1.22

nmol/l

0.26

Urinary track infection

214

625

1.72

11.15

1.9

1.43

1.31

nmol/l

0.71

168

491

Adhesive capsulitis of shoulder

373

2.27

11.11

1.6

1.5

1.11

1.26

nmol/l

0.63

268

Non-selective monoamine reuptake inhibitors

158

842

1.81

11.10

1.4

1.5

1.27

1.20

nmol/l

0.25

109

649

487

1740

1.42

11.09

1.6

1.36

1.26

nmol/l

0.78

366

1326

Otitis externa

116

585

1.99

11.04

2.0

1.6

1.31

1.27

nmol/l

0.14

437

Gastroduodenal ulcer

118

597

1.98

11.02

1.6

1.3

1.27

1.22

nmol/l

0.19

443

Gout, strict definition

466

2.12

10.96

1.3

1.72

1.09

nmol/l

5.41

340

Diabetic neuropathy

152

841

1.83

10.88

1.5

1.4

1.03

1.24

nmol/l

1.30

108

616

Pre-eclampsia or eclampsia

415

2.18

10.87

1.9

1.8

1.38

1.30

nmol/l

0.24

320

Syncope and collapse

196

967

1.70

10.84

1.4

1.5

1.46

1.25

nmol/l

1.15

147

732

Hyperkinetic disorders, excluding more controls

177

2.81

10.83

2.1

2.5

1.38

1.43

nmol/l

0.08

149

Diseases of pulp and periapical tissues and dental caries

263

839

1.61

10.83

1.4

1.5

1.25

1.27

nmol/l

0.07

188

637

Pre-eclampsia

384

2.22

10.80

1.9

1.8

1.45

1.35

nmol/l

0.31

295

COPD-related respiratory insufficiency

261

2.51

10.79

1.5

1.3

1.49

1.15

nmol/l

1.38

189

Hepatic failure, not elsewhere classified

4.01

10.78

1.5

1.4

1.29

1.12

nmol/l

0.44

Spondylopathies

333

1304

1.51

10.77

1.5

1.17

1.29

nmol/l

1.22

245

994

Amputation of foot

4.64

10.75

1.4

1.3

1.13

1.04

nmol/l

0.15

Malignant neoplasm of digestive organs

196

886

1.70

10.69

1.4

1.06

1.26

nmol/l

2.35

152

636

Sequelae of injuries of head

124

3.27

10.69

1.5

1.4

0.86

1.28

nmol/l

2.73

100

Alcohol use disorder, ICD-based

202

1222

1.66

10.56

1.5

1.10

1.31

nmol/l

2.25

148

924

Agoraphobia

4.85

10.50

1.5

1.9

1.23

1.42

nmol/l

0.21

Cystitis

343

1368

1.49

10.48

1.6

1.35

1.28

nmol/l

0.37

256

1051

Irregular menses

181

790

1.72

10.46

2.0

1.8

1.45

1.35

nmol/l

0.51

144

624

Polycystic ovarian syndrome, broad definition

184

2.79

10.46

2.7

2.4

1.71

1.42

nmol/l

0.67

153

Myalgia

106

529

2.01

10.41

2.0

1.7

1.16

1.28

nmol/l

0.56

393

Caries of dentine, including avohilmo

308

1027

1.54

10.38

1.5

1.24

1.26

nmol/l

0.12

227

771

Dental operations

250

799

1.61

10.37

1.4

1.5

1.18

1.24

nmol/l

0.35

183

598

Epilepsy

130

694

1.87

10.37

1.5

1.25

1.18

nmol/l

0.37

537

All anxiety disorders

270

1353

1.55

10.33

1.7

1.40

1.28

nmol/l

0.85

192

1055

Excessive, frequent and irregular menstruation

144

409

1.88

10.31

1.9

1.8

1.45

1.28

nmol/l

0.72

101

318

Alcohol abuse, main dg, excluding more controls

329

2.29

10.25

1.4

1.5

1.25

1.22

nmol/l

0.07

251

196

1178

1.66

10.18

1.6

1.7

1.41

1.23

nmol/l

1.15

151

896

Other joint disorders

377

1345

1.46

10.18

1.9

1.6

1.35

1.23

nmol/l

1.17

291

1039

Supplementary factors related to causes of morbidity and mortality classified elsewhere

146

816

1.80

10.17

1.5

1.6

1.26

nmol/l

0.00

621

Type of accident

136

744

1.84

10.17

1.5

1.6

1.28

1.25

nmol/l

0.11

558

Mental and behavioural disorders due to alcohol

241

1461

1.58

10.16

1.4

1.5

1.13

1.29

nmol/l

1.28

177

1115

Other respiratory disorders and diseases

480

2.05

10.16

1.3

1.4

1.33

1.18

nmol/l

0.52

352

Other diseases of the respiratory system

480

2.05

10.16

1.3

1.4

1.33

1.18

nmol/l

0.52

352

Intestinal infectious diseases, including avohilmo, including avohilmo

494

1983

1.39

10.14

1.7

1.5

1.29

1.28

nmol/l

0.06

363

1523

Unspecified mental disorder

183

1092

1.68

10.09

1.4

1.7

1.42

1.22

nmol/l

1.43

135

839

Vitamin B12 deficiency anaemia

199

2.68

10.09

1.9

1.4

1.01

1.12

nmol/l

0.38

144

Unstable angina pectoris

161

721

1.76

10.07

1.2

1.3

1.37

1.18

nmol/l

0.95

126

518

Other diseases of the digestive system

146

823

1.78

9.89

1.5

1.3

1.23

1.18

nmol/l

0.18

106

597

Gastric ulcer

379

2.17

9.89

1.6

1.3

1.26

1.18

nmol/l

0.30

281

Hypothyreosis and Thyroxine purchase for inclusion criteria

382

1742

1.44

9.85

1.7

1.6

1.21

1.30

nmol/l

0.79

284

1329

Fracture of lower leg, including ankle

244

1545

1.55

9.77

1.5

1.6

1.15

1.28

nmol/l

0.94

176

1178

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

433

1984

1.40

9.64

1.7

1.6

1.33

1.27

nmol/l

0.45

324

1525

Other diseases of intestine

377

2.16

9.62

1.4

1.20

1.26

nmol/l

0.18

292

Hypothyroidism, other/unspecified

370

1692

1.44

9.61

1.7

1.6

1.22

1.31

nmol/l

0.79

275

1290

Open wound of ankle and foot

246

2.46

9.58

2.1

1.6

1.06

1.23

nmol/l

0.54

185

Chronic lower respiratory diseases

513

1976

1.37

9.56

1.6

1.28

1.27

nmol/l

0.05

390

1510

Benign neoplasm: Colon, unspecified

121

652

1.86

9.53

1.6

1.3

1.22

nmol/l

0.02

478

Hernia of abdominal wall

213

1342

1.59

9.51

1.6

1.5

1.37

1.24

nmol/l

0.76

154

1015

Vascular disorders of the intestines

128

3.07

9.50

1.3

1.4

1.35

1.19

nmol/l

0.27

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

230

2.50

9.42

1.4

1.48

1.24

nmol/l

0.49

166

Volume depletion

178

2.71

9.39

1.5

1.3

1.12

1.18

nmol/l

0.10

134

Cough

166

917

1.69

9.37

1.7

1.5

1.53

1.20

nmol/l

2.10

118

694

Kela-code for severe mental illness

164

971

1.69

9.37

1.4

1.7

1.43

1.23

nmol/l

1.35

125

739

Mental and behavioural disorders due to alcohol, excluding acute intoxication

213

1335

1.59

9.35

1.5

1.10

1.29

nmol/l

1.71

154

1017

Chronic hepatitis, not elsewhere classified

4.00

9.34

1.4

1.5

1.54

1.21

nmol/l

0.67

Other acute lower respiratory infections

235

1446

1.55

9.32

1.6

1.33

1.24

nmol/l

0.53

174

1096

Asthma (only as main-diagnosis), excluding more controls

270

974

1.53

9.31

1.7

1.6

1.32

1.22

nmol/l

0.65

208

766

Ventral hernia

116

622

1.87

9.29

1.6

1.4

1.36

1.25

nmol/l

0.41

469

Visual disturbances

211

1334

1.59

9.29

1.5

1.6

1.17

1.25

nmol/l

0.47

150

1008

Acute bronchitis

179

1067

1.65

9.22

1.6

1.29

1.22

nmol/l

0.35

132

806

Disorders of calcium metabolism

120

3.11

9.21

1.7

1.4

1.29

1.15

nmol/l

0.31

Superficial injury of lower leg

118

638

1.86

9.21

1.8

1.7

1.29

1.27

nmol/l

0.05

492

Other gastritis (incl. Duodenitis)

100

512

1.96

9.20

1.4

1.20

1.24

nmol/l

0.12

386

Other and unspecified nonorganic psychotic disorders

438

2.04

9.15

1.4

1.8

1.40

1.29

nmol/l

0.41

327

Focal brain injury

3.51

9.06

1.3

1.32

1.08

nmol/l

0.53

Conduction disorders

134

600

1.80

9.05

1.5

1.4

1.53

1.22

nmol/l

1.08

436

Non-ischemic cardiomyopathy

130

571

1.81

9.03

1.5

1.3

1.41

1.19

nmol/l

1.08

417

Ischaemic Stroke, excluding all haemorrhages

244

1172

1.54

8.91

1.4

1.3

1.19

1.27

nmol/l

0.62

188

864

Causalgia

6.96

8.90

1.2

1.7

1.16

1.08

nmol/l

0.09

Other abnormal uterine and vaginal bleeding

306

2.07

8.87

1.7

1.6

1.32

1.19

nmol/l

0.43

231

Finngen Rheumatological endpoints

411

1671

1.40

8.87

1.7

1.6

1.29

1.26

nmol/l

0.26

309

1291

Other or unspecified ileus, impaction or obstruction

423

2.04

8.86

1.3

1.4

1.19

1.26

nmol/l

0.23

320

Other arthrosis

243

1060

1.54

8.84

1.5

1.4

1.22

1.19

nmol/l

0.22

192

811

Acute upper respiratory infections

439

1910

1.38

8.83

1.6

1.33

1.27

nmol/l

0.46

331

1456

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

134

2.93

8.80

2.1

1.8

1.65

1.40

nmol/l

0.64

106

Arthropathies

378

1345

1.42

8.79

1.8

1.6

1.39

1.23

nmol/l

1.70

281

1039

Stroke, including SAH

269

1291

1.50

8.74

1.4

1.3

1.20

1.29

nmol/l

0.67

209

951

Rheumatism, unspecified

257

2.35

8.73

1.5

1.4

1.17

1.27

nmol/l

0.29

185

Diseases of external ear

159

953

1.67

8.72

1.9

1.6

1.35

1.23

nmol/l

0.50

104

727

Exclusions for E4_PCOS_CONSORTIUM

273

1139

1.50

8.66

1.6

1.8

1.28

1.31

nmol/l

0.16

195

892

Other degenerative diseases of the nervous system

102

384

1.94

8.65

1.3

1.4

1.25

1.27

nmol/l

0.05

308

Sequelae of external causes of morbidity and mortality

119

662

1.81

8.52

1.5

1.11

1.25

nmol/l

0.88

497

Acute upper respiratory infections of multiple and unspecified sites

324

1649

1.44

8.50

1.7

1.6

1.31

1.26

nmol/l

0.31

247

1264

Stroke, excluding SAH

257

1237

1.50

8.49

1.4

1.3

1.20

1.27

nmol/l

0.44

199

904

Acute sinusitis

226

1347

1.53

8.39

1.6

1.7

1.32

1.25

nmol/l

0.40

168

1037

Other disorders of penis

243

2.36

8.38

1.4

0.95

1.19

nmol/l

1.33

183

Convulsions, not elsewhere classified

102

537

1.88

8.34

1.6

1.33

1.24

nmol/l

0.31

411

Abnormal findings on diagnostic imaging of lung

212

1304

1.54

8.29

1.5

1.4

1.37

1.24

nmol/l

0.68

160

967

Flat foot [pes planus] (acquired)

214

2.45

8.29

1.5

1.3

1.30

1.22

nmol/l

0.19

151

Diseases of the respiratory system

254

839

1.52

8.26

1.6

1.35

1.22

nmol/l

0.92

191

653

Bipolar affective disorders

394

2.04

8.26

1.4

1.8

1.21

1.32

nmol/l

0.36

299

Intestinal stricture

138

809

1.71

8.25

1.3

1.4

1.22

nmol/l

0.01

109

599

Other disorders of lacrimal gland

159

968

1.65

8.24

1.6

1.5

1.28

1.27

nmol/l

0.04

111

733

Viral and other specified intestinal infections

451

1.95

8.22

1.8

1.9

1.15

1.27

nmol/l

0.44

351

Other CVD

463

1.95

8.22

1.3

1.04

1.20

nmol/l

0.75

336

AV-block

357

2.02

8.20

1.3

1.44

1.20

nmol/l

0.55

258

Dental caries, including avohilmo

284

984

1.48

8.18

1.5

1.25

1.26

nmol/l

0.06

206

742

Disorders of skin appendages

212

1376

1.54

8.17

1.8

1.7

1.21

1.25

nmol/l

0.26

154

1054

Sequelae with surgical and medical care as external cause

506

1.91

8.17

1.5

1.4

1.14

1.24

nmol/l

0.53

370

Enterocolitis due to Clostridium difficile

234

2.37

8.15

1.7

1.4

1.35

1.21

nmol/l

0.32

166

Viral infections characterized by skin and mucous membrane lesions

187

1187

1.58

8.13

1.8

1.6

1.28

1.25

nmol/l

0.16

142

902

Traumatic subdural haemorrhage

201

2.43

8.09

1.5

1.3

1.17

1.18

nmol/l

0.03

160

GI-bleeding

139

822

1.70

8.05

1.5

1.3

1.25

1.18

nmol/l

0.31

103

598

Exposure to other specified factors

345

2123

1.40

8.00

1.7

1.6

1.27

1.28

nmol/l

0.07

251

1631

Disorders of the thyroid gland

389

1832

1.38

7.99

1.7

1.6

1.17

1.32

nmol/l

1.66

287

1395

Barrett oesophagus

104

3.11

7.99

1.3

1.4

1.54

1.21

nmol/l

0.40

Use of hypnotics and sedatives

451

1910

1.35

7.97

1.5

1.6

1.23

1.27

nmol/l

0.26

330

1478

Hypotension

386

2.03

7.96

1.3

1.11

1.18

nmol/l

0.22

279

Pre-eclampsia or poor fetal growth

112

622

1.80

7.96

2.0

1.38

1.37

nmol/l

0.03

495

Other disorders of adrenal gland

3.23

7.95

1.9

1.4

2.18

1.27

nmol/l

1.67

Fibromyalgia

171

2.59

7.91

2.3

1.7

1.62

1.37

nmol/l

0.78

127

Asthma (only as main-diagnosis)

276

1050

1.47

7.90

1.7

1.6

1.32

1.24

nmol/l

0.48

213

815

Other diseases of anus and rectum

129

749

1.72

7.89

1.7

1.5

1.35

1.28

nmol/l

0.27

565

Calcific aortic valvular stenosis, operated

124

687

1.74

7.88

1.4

1.3

1.23

1.21

nmol/l

0.09

495

Calcific aortic valvular stenosis

124

687

1.74

7.88

1.4

1.3

1.23

1.21

nmol/l

0.09

495

Operations 2 for CAVS

124

687

1.74

7.88

1.4

1.3

1.23

1.21

nmol/l

0.09

495

Calcific aortic valvular stenosis, diagnosis (helper)

124

687

1.74

7.88

1.4

1.3

1.23

1.21

nmol/l

0.09

495

Candidiasis, including avohilmo

129

753

1.72

7.85

1.7

1.8

1.38

1.32

nmol/l

0.20

570

Candidiasis

315

2.14

7.84

1.6

1.50

1.32

nmol/l

0.52

234

Calcific aortic valvular stenosis, including rheumatic fever

124

688

1.74

7.81

1.4

1.3

1.23

1.21

nmol/l

0.09

496

Other symptoms and signs involving the digestive system and abdomen

343

2.08

7.75

1.7

1.5

1.23

1.22

nmol/l

0.02

257

Transport accidents

192

1028

1.56

7.71

1.7

1.6

1.24

1.32

nmol/l

0.28

136

825

Other bacterial intestinal infections

412

1.97

7.68

1.6

1.4

1.28

1.26

nmol/l

0.05

305

Disorders of vitreous body

215

1356

1.51

7.68

1.7

1.4

1.12

1.28

nmol/l

0.93

145

1022

Other diseases of biliary tract

174

2.55

7.65

1.9

1.3

1.13

1.18

nmol/l

0.12

126

External causes of morbidity and mortality

249

834

1.50

7.63

1.6

1.7

1.27

1.34

nmol/l

0.36

181

667

Striking against or struck by other objects

154

948

1.63

7.62

1.7

1.6

1.20

1.25

nmol/l

0.18

106

720

Respiratory insufficiency

145

2.70

7.61

1.3

1.4

1.73

1.18

nmol/l

1.39

101

Autoimmune diseases related-to ILD

355

2153

1.38

7.61

1.6

1.34

1.26

nmol/l

0.61

266

1644

Bell's palsy

236

2.30

7.56

1.7

1.4

1.28

1.21

nmol/l

0.16

173

Abnormalities of heart beat

140

819

1.66

7.51

1.8

1.6

1.25

1.19

nmol/l

0.27

103

620

Nonorganic sleeping disorders, excluding more controls

436

1.93

7.51

1.8

1.9

1.19

1.31

nmol/l

0.52

332

Other specified and unspecified personality disorders

194

2.44

7.48

1.3

1.6

1.23

1.30

nmol/l

0.16

151

Disorders of vitreous body and globe

220

1394

1.50

7.47

1.7

1.4

1.13

1.28

nmol/l

0.80

148

1052

Coronary artery bypass grafting

113

471

1.78

7.47

1.2

1.3

1.24

1.18

nmol/l

0.24

341

Lateral epicondylitis

295

2.15

7.47

1.8

1.6

1.05

1.29

nmol/l

1.29

213

Other diseases of hard tissues of teeth

215

726

1.54

7.46

1.4

1.5

1.29

1.24

nmol/l

0.24

144

557

Chronic laryngitis and laryngotracheitis

315

2.11

7.46

1.7

1.5

1.60

1.32

nmol/l

0.81

226

Other external causes of accidental injury

314

1106

1.42

7.44

1.7

1.6

1.29

1.32

nmol/l

0.12

229

883

Injuries to the ankle and foot

305

1853

1.41

7.43

1.7

1.20

1.28

nmol/l

0.60

224

1433

Fungal Sepsis

3.22

7.40

1.4

1.74

1.16

nmol/l

1.01

Decubitus ulcer and pressure area

131

2.77

7.38

1.3

1.4

1.18

1.13

nmol/l

0.07

Dementia, including avohilmo

186

813

1.56

7.37

1.4

1.3

1.21

nmol/l

0.01

128

597

Assault

317

2.09

7.34

1.5

1.7

1.01

1.29

nmol/l

1.28

241

Implicit fungal Sepsis, including avohilmo

143

2.68

7.31

1.6

1.4

1.43

1.29

nmol/l

0.22

102

Accidents

313

1106

1.42

7.30

1.7

1.6

1.33

1.32

nmol/l

0.09

228

883

Dysphagia

104

584

1.79

7.28

1.5

1.4

1.08

1.24

nmol/l

0.88

442

Dementia

176

764

1.58

7.27

1.4

1.3

1.25

1.21

nmol/l

0.14

121

560

Smoking dependency

222

2.31

7.24

1.7

1.4

1.27

1.23

nmol/l

0.09

162

Mental and behavioural disorders due to tobacco

222

2.31

7.24

1.7

1.4

1.27

1.23

nmol/l

0.09

163

Diseases of the musculoskeletal system and connective tissue

205

667

1.54

7.23

1.6

1.7

1.35

1.30

nmol/l

0.28

158

521

Benign neoplasm of other and unspecified endocrine glands

313

2.09

7.19

1.4

1.37

1.26

nmol/l

0.35

227

Disorders of lacrimal system

182

1164

1.54

7.19

1.6

1.24

1.27

nmol/l

0.10

128

881

Acute alcohol intoxication, ICD10

529

1.82

7.17

1.3

1.6

1.19

1.24

nmol/l

0.13

399

Hyperkinetic disorders

229

2.27

7.16

2.1

2.4

1.38

1.35

nmol/l

0.07

190

Lesion of ulnar nerve

307

2.10

7.15

1.3

1.4

1.37

1.23

nmol/l

0.42

224

Dermatitis

263

1802

1.43

7.15

1.6

1.5

1.26

1.28

nmol/l

0.08

203

1372

Hernia

388

1909

1.35

7.14

1.6

1.5

1.30

1.28

nmol/l

0.18

283

1457

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

224

1469

1.47

7.11

1.6

1.5

1.42

1.25

nmol/l

1.25

168

1117

Unspecified fall

213

1410

1.49

7.07

1.5

1.6

1.15

1.26

nmol/l

0.73

160

1064

Post-traumatic stress disorder

146

2.62

7.02

1.7

2.3

1.34

1.59

nmol/l

0.55

117

Certain disorders involving the immune mechanism

454

1.88

7.02

1.3

1.4

1.24

1.25

nmol/l

0.04

335

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.87

6.96

1.3

1.11

1.17

nmol/l

0.12

Schizophrenia, schizotypal and delusional disorders

137

841

1.63

6.95

1.4

1.7

1.34

1.23

nmol/l

0.59

107

640

Fracture of rib(s), sternum and thoracic spine

141

872

1.62

6.95

1.5

1.4

1.16

1.22

nmol/l

0.21

103

643

Hypothyroidism, strict autoimmune, 3 medication purchases required

325

1580

1.38

6.94

1.8

1.6

1.24

1.29

nmol/l

0.32

240

1203

Persistent mood disorders

442

1.89

6.92

1.5

1.6

1.39

1.26

nmol/l

0.40

327

Internal derangement of knee

163

1034

1.56

6.90

1.6

1.5

1.26

1.18

nmol/l

0.34

109

792

Alzheimer disease, excluding more controls

212

2.08

6.88

1.2

1.3

1.32

1.24

nmol/l

0.13

169

Arthrosis

300

1168

1.41

6.88

1.7

1.5

1.26

1.21

nmol/l

0.38

228

899

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

139

859

1.62

6.87

1.7

1.6

1.31

1.24

nmol/l

0.33

104

642

Disturbance of activity and attention

215

2.28

6.86

2.1

2.4

1.39

1.32

nmol/l

0.13

179

Unspecified jaundice

103

2.94

6.85

1.7

1.4

1.15

1.25

nmol/l

0.21

Other neurological diseases

296

1646

1.40

6.84

1.4

1.5

1.18

1.28

nmol/l

0.75

224

1229

Viral and other specified intestinal infections, including avohilmo

114

644

1.71

6.82

1.8

1.14

1.29

nmol/l

0.76

500

Emotionally unstable personality disorder

241

2.21

6.79

1.5

1.9

1.02

1.41

nmol/l

1.72

198

Ingrowing nail

109

2.87

6.79

2.0

1.4

1.03

1.25

nmol/l

0.51

Injuries to the wrist and hand

419

2098

1.33

6.78

1.6

1.25

1.29

nmol/l

0.30

308

1616

Cardiac arrest

3.10

6.77

1.2

1.31

1.29

nmol/l

0.03

Noninfective enteritis and colitis

195

1304

1.50

6.76

1.6

1.29

1.23

nmol/l

0.37

146

993

Disorders of eyelid, lacrimal system and orbit

353

1912

1.35

6.71

1.6

1.19

1.30

nmol/l

1.00

258

1459

Open wound of head

230

1495

1.45

6.68

1.5

1.21

1.27

nmol/l

0.30

163

1130

Injuries to the thorax

200

1349

1.48

6.67

1.7

1.5

1.18

1.26

nmol/l

0.39

138

1024

Mycoses

123

744

1.66

6.64

1.5

1.6

1.32

1.28

nmol/l

0.12

100

555

Asthma (diagnoses ohter than nonallergic)

355

2130

1.35

6.64

1.6

1.32

1.28

nmol/l

0.25

277

1614

Haemorrhage from respiratory passages

138

757

1.62

6.63

1.4

1.35

1.19

nmol/l

0.85

106

553

ILD medications: immunosuppressive drugs

263

1690

1.41

6.63

1.6

1.33

1.25

nmol/l

0.46

197

1309

Iron deficiency anaemia secondary to blood loss (chronic)

351

1.97

6.60

1.4

1.61

1.20

nmol/l

1.24

255

Schizophrenia or delusion

135

838

1.62

6.58

1.4

1.7

1.37

1.23

nmol/l

0.74

105

638

Abnormal findings on diagnostic imaging of other body structures

345

1.98

6.56

1.5

1.4

1.31

1.26

nmol/l

0.15

247

COPD (mode)

127

601

1.65

6.51

1.4

1.39

1.19

nmol/l

0.96

447

Maternal care for other conditions predominantly related to pregnancy

337

1.97

6.49

1.9

2.0

1.26

1.39

nmol/l

0.48

264

Vascular dementia

152

2.49

6.48

1.6

1.3

0.94

1.09

nmol/l

0.48

106

Leisure time condition

438

1.86

6.47

1.4

1.6

1.18

1.24

nmol/l

0.22

322

Symptoms and signs concerning food and fluid intake

220

2.23

6.46

1.8

1.5

1.21

1.22

nmol/l

0.02

160

Other and unspecified mononeuropathies, also in other diseases

3.55

6.45

1.5

1.12

1.18

nmol/l

0.09

Streptococcal septicaemia, including avohilmo

209

2.26

6.39

1.5

1.4

0.96

1.19

nmol/l

0.63

152

Mental retardation, excluding more controls

3.77

6.34

1.2

1.6

1.48

1.34

nmol/l

0.09

Hypopituitarism

160

2.45

6.34

1.5

1.57

1.24

nmol/l

1.01

119

Implicit fungal Sepsis

3.12

6.32

1.3

1.4

1.66

1.17

nmol/l

0.69

Early onset COPD

103

603

1.72

6.31

1.4

1.3

1.32

1.20

nmol/l

0.46

449

Open wound of lower leg

350

1.95

6.31

1.5

1.6

1.14

1.19

nmol/l

0.18

257

Other reaction to severe stress, and adjustment disorders

144

917

1.57

6.30

1.8

1.10

1.26

nmol/l

1.05

104

717

Streptococcal septicaemia

204

2.27

6.30

1.5

1.4

0.99

1.20

nmol/l

0.55

148

Other and unspecified mood [affective] disorders

131

2.61

6.29

1.6

2.0

1.30

1.33

nmol/l

0.04

106

Diplopia

303

2.02

6.27

1.5

1.4

1.16

1.24

nmol/l

0.20

216

Non-rheumatic valve diseases

189

903

1.50

6.26

1.4

1.19

1.24

nmol/l

0.20

144

664

Inflammatory diseases of female pelvic organs

216

1015

1.46

6.26

1.8

1.46

1.33

nmol/l

0.87

152

802

Otitis externa, unspecified

263

2.10

6.25

2.2

1.5

1.29

1.25

nmol/l

0.09

194

Panic disorder

310

2.01

6.25

1.9

2.0

1.42

1.40

nmol/l

0.04

240

Valvular heart disease excluding rheumatic fever

189

906

1.49

6.19

1.4

1.19

1.24

nmol/l

0.23

144

666

Alcohol abuse, main dg

402

1.87

6.18

1.4

1.5

1.25

1.18

nmol/l

0.16

299

Disease of hard tissues of teeth, NOS

202

711

1.49

6.18

1.5

1.37

1.23

nmol/l

0.94

138

545

COPD related to multimorbidity

167

931

1.52

6.12

1.4

1.3

1.39

1.21

nmol/l

1.05

114

692

Artrosis, including avohilmo

349

1422

1.35

6.10

1.8

1.5

1.32

1.26

nmol/l

0.36

261

1094

Other anxiety disorders

182

1041

1.49

6.09

1.7

1.8

1.30

1.28

nmol/l

0.10

132

818

Exposure to unspecified factor

414

2159

1.31

6.09

1.7

1.6

1.27

1.29

nmol/l

0.10

295

1668

Other medical care

182

1027

1.49

6.07

1.3

1.5

1.17

1.29

nmol/l

0.74

133

755

Asthma, including avohilmo

480

2059

1.28

6.04

1.6

1.32

1.27

nmol/l

0.41

369

1571

Myocardial infarction, unclassifiable

424

1.80

6.03

1.4

1.3

1.21

1.25

nmol/l

0.09

305

Speech and linguistic disorders, excluding more controls

2.79

6.01

1.3

2.1

1.17

1.25

nmol/l

0.10

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

395

1903

1.31

6.00

1.5

1.6

1.28

nmol/l

0.01

286

1457

Other noninfective gastroenteritis and colitis

102

604

1.69

5.99

1.7

1.6

1.26

1.27

nmol/l

0.02

446

All influenza (not pneumonia)

343

1.93

5.98

1.7

1.6

1.35

1.17

nmol/l

0.69

249

Neuromuscular dysfunction of bladder

209

2.21

5.96

1.7

1.4

1.30

1.19

nmol/l

0.20

150

Other and unspecified local infections of skin and subcutaneous tissue

222

2.17

5.96

1.8

1.4

1.22

1.29

nmol/l

0.15

164

Fall on same level involving ice and snow

239

1709

1.40

5.89

1.5

1.6

1.21

1.28

nmol/l

0.36

173

1300

Injuries to the abdomen, lower back, lumbar spine and pelvis

165

1086

1.50

5.85

1.5

1.6

1.26

nmol/l

0.03

124

817

Explicit bacterial Sepsis

224

2.15

5.83

1.4

1.3

1.02

1.20

nmol/l

0.49

156

Diseases of middle ear and mastoid

226

1304

1.42

5.82

1.8

1.7

1.41

1.23

nmol/l

1.28

169

1010

Other diseases of upper respiratory tract

437

1760

1.29

5.80

1.7

1.5

1.30

1.26

nmol/l

0.31

329

1344

Explicit bacterial Sepsis, including avohilmo

231

2.13

5.80

1.4

1.3

0.99

1.20

nmol/l

0.59

160

Certain infectious and parasitic diseases, including avohilmo

275

993

1.39

5.79

1.6

1.31

1.30

nmol/l

0.05

203

779

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

155

2.40

5.79

1.1

1.4

1.24

1.12

nmol/l

0.32

110

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

350

1.85

5.75

2.0

2.3

1.57

1.36

nmol/l

0.64

282

Algoneurodystrophy

3.27

5.74

1.2

1.6

1.05

1.38

nmol/l

0.72

Bacterial intestinal infections, IBD co-morbidities

435

1.80

5.70

1.6

1.3

1.28

1.24

nmol/l

0.09

315

Gonarthrosis

265

1081

1.39

5.67

1.6

1.4

1.28

1.20

nmol/l

0.55

194

829

Heartburn

240

2.09

5.66

1.7

1.4

1.69

1.26

nmol/l

1.55

180

Noninfectious colitis NAS

322

1.93

5.65

1.5

1.23

nmol/l

0.01

235

Other bacterial intestinal infections, including avohilmo

577

1.69

5.65

1.6

1.5

1.25

1.26

nmol/l

0.03

433

KRA_PSY_EATING, excluding more controls

108

2.67

5.64

2.4

2.3

1.34

1.45

nmol/l

0.18

Transient ischemic attack

208

1160

1.43

5.63

1.4

1.3

1.15

1.27

nmol/l

0.87

159

858

Dermatitis and eczema

451

2088

1.28

5.62

1.7

1.6

1.28

nmol/l

0.01

338

1599

Follow-up examination after treatment for malignant neoplasms

133

2.49

5.60

1.9

1.3

1.07

1.32

nmol/l

0.78

114

Special screening examination for neoplasms

104

2.71

5.59

1.9

1.6

1.00

1.31

nmol/l

1.36

Sequelae of cerebrovascular disease

144

804

1.53

5.56

1.3

1.13

1.22

nmol/l

0.50

104

598

Neoplasms

300

1161

1.36

5.55

1.7

1.25

1.31

nmol/l

0.40

224

908

Diagnoses used for exclusion with ILD

103

626

1.65

5.54

1.3

1.4

1.15

1.26

nmol/l

0.43

463

Superficial injury of wrist and hand

513

1.72

5.53

1.8

1.7

1.15

1.29

nmol/l

0.67

386

Disorders resulting from impaired renal tubular function

3.09

5.50

1.2

1.5

1.56

1.21

nmol/l

0.40

Injuries to the shoulder and upper arm

351

2067

1.31

5.50

1.5

1.18

1.29

nmol/l

1.13

270

1564

Gingivitis and periodontal diseases

388

1537

1.30

5.49

1.5

1.6

1.26

1.27

nmol/l

0.06

284

1196

Other diseases of stomach and duodenum

135

2.46

5.45

1.4

1.11

1.20

nmol/l

0.21

Sequelae of injuries of upper limb

244

2.06

5.45

1.9

1.4

1.17

1.27

nmol/l

0.35

178

Calculus of kidney and ureter

127

816

1.56

5.44

1.5

1.4

1.40

1.21

nmol/l

0.83

606

Other shoulder lesions

192

2.20

5.40

1.7

1.5

1.19

1.37

nmol/l

0.38

138

Migraine

166

874

1.48

5.37

1.9

1.8

1.44

1.22

nmol/l

1.45

127

699

Undetermined asthma, excluding more controls

245

2.05

5.37

1.3

1.6

1.38

1.24

nmol/l

0.30

182

Other symptoms and signs involving the circulatory and respiratory systems

136

2.44

5.36

1.3

1.4

1.18

1.24

nmol/l

0.12

Burns and corrosions

336

1.88

5.33

1.7

1.6

1.06

1.21

nmol/l

0.42

250

Other otitis externa (chronic)

155

2.34

5.33

2.1

1.4

1.30

1.27

nmol/l

0.03

119

Alcohol dependence

120

766

1.57

5.30

1.4

1.11

1.24

nmol/l

0.72

572

Periapical abscess

197

1391

1.42

5.30

1.6

1.5

1.40

1.24

nmol/l

1.00

151

1049

Ulcer of oesophagus

131

2.46

5.28

1.3

1.4

1.65

1.16

nmol/l

0.86

Papulosquamous disorders

163

1113

1.47

5.25

1.6

1.5

1.47

1.21

nmol/l

1.83

125

840

Speech disturbances, not elsewhere classified

201

2.15

5.24

1.6

1.4

1.46

1.13

nmol/l

0.83

144

Other local infections of skin and subcutaneous tissue

241

2.04

5.24

1.8

1.4

1.20

1.27

nmol/l

0.17

177

Other disorders of kidney and ureter

317

1.90

5.24

1.2

1.4

1.49

1.18

nmol/l

0.91

225

Diseases of the myoneural junction and muscle

296

1.94

5.23

1.2

1.4

1.87

1.20

nmol/l

2.14

212

Other diseases of pleura

181

1092

1.44

5.23

1.3

1.30

1.23

nmol/l

0.33

128

810

Hypogonadotropic hypogonadism

3.08

5.23

1.6

1.4

1.65

1.32

nmol/l

0.60

Wet age-related macular degeneration

326

1.87

5.20

1.4

1.3

1.25

1.24

nmol/l

0.02

238

Other mental disorders due to brain damage and dysfunction and to physical disease

242

2.03

5.18

1.3

1.04

1.21

nmol/l

0.48

175

Hypertensive Renal Disease

3.50

5.18

1.0

1.4

1.03

1.07

nmol/l

—

Sarcoidosis

312

1.90

5.14

1.3

1.4

1.24

1.22

nmol/l

0.04

229

Urolithiasis

134

884

1.52

5.12

1.5

1.4

1.37

1.22

nmol/l

0.63

657

Unspecified kidney failure

203

2.13

5.12

1.4

1.30

1.14

nmol/l

0.35

140

Fentanyl

196

2.15

5.12

1.5

1.3

1.08

1.21

nmol/l

0.27

142

Other enthesopathies

116

741

1.57

5.11

1.6

1.11

1.28

nmol/l

1.22

556

Haemorrhoids and perianal venous thrombosis

133

870

1.52

5.10

1.3

1.5

1.31

1.28

nmol/l

0.10

101

661

Undetermined asthma

250

2.01

5.10

1.3

1.6

1.38

1.25

nmol/l

0.27

187

Late syphilis

5.77

5.09

2.0

1.9

1.42

1.11

nmol/l

—

Other respiratory diseases principally affecting the interstitium

422

1.76

5.06

1.5

1.3

1.34

1.21

nmol/l

0.39

300

Vitamin deficiency

2.78

5.04

1.9

1.5

0.72

1.14

nmol/l

1.93

Vitamin deficiency, wide

2.78

5.04

1.9

1.5

0.72

1.14

nmol/l

1.93

Cholangitis (primary sclerosing, PSC)

122

2.48

5.04

1.5

1.4

1.03

1.28

nmol/l

0.75

Other female pelvic inflammatory diseases

329

1.86

5.01

1.7

1.25

1.32

nmol/l

0.17

249

Fissure and fistula of anal and rectal regions

597

1.63

5.01

1.8

1.5

1.18

1.27

nmol/l

0.30

468

Superficial injury of head

582

1.63

4.97

1.5

1.33

1.26

nmol/l

0.24

425

Other and unspecified injuries of head

160

2.26

4.97

1.8

1.4

1.44

1.21

nmol/l

0.39

115

Mixed and other personality disorders

173

2.21

4.96

1.6

1.27

1.36

nmol/l

0.19

136

Other disorders of patella

396

1.77

4.93

2.2

1.7

1.29

1.23

nmol/l

0.19

306

Fibroblastic disorders

562

1.64

4.90

1.7

1.4

1.21

1.27

nmol/l

0.21

418

Late syphilis, including avohilmo

4.63

4.89

1.9

1.8

1.64

1.16

nmol/l

—

ILD, hospital admission 2, with pulmonary infections

194

2.12

4.87

1.4

1.3

1.23

1.15

nmol/l

0.21

131

Trigger finger

318

1.86

4.87

1.5

1.27

1.33

nmol/l

0.12

232

Enlarged lymph nodes

349

1.81

4.77

1.6

1.5

1.32

1.27

nmol/l

0.12

261

Follicular cysts of skin and subcutaneous tissue

460

1.70

4.77

1.7

1.5

1.21

1.25

nmol/l

0.13

342

Use of disulfiram, acamprosate or naltrexone

223

2.03

4.75

1.5

1.4

1.04

1.22

nmol/l

0.64

167

Fracture of foot, except ankle

101

637

1.59

4.75

1.6

1.7

1.17

1.32

nmol/l

0.64

489

Acute peritonitis

132

2.36

4.74

2.2

1.4

1.07

1.23

nmol/l

0.24

Disorders of psychological development

181

2.11

4.73

1.2

2.3

1.19

1.33

nmol/l

0.25

144

Nonischemic cardiomyopathy

203

2.08

4.72

1.3

1.43

1.16

nmol/l

0.57

149

Polyarthrosis

427

1.69

4.72

1.5

1.3

1.33

1.17

nmol/l

0.63

324

Chronic diseases of tonsils and adenoids

304

1463

1.31

4.71

1.8

1.6

1.24

1.25

nmol/l

0.07

240

1127

Hirsutism in women

4.73

4.69

2.1

2.0

1.46

1.41

nmol/l

0.05

Mental and behavioural disorders due to opioids

3.04

4.67

1.2

1.8

1.13

1.26

nmol/l

0.20

Any dementia, excluding more controls

133

607

1.51

4.66

1.3

1.20

1.19

nmol/l

0.03

447

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

152

2.25

4.66

1.4

1.38

1.14

nmol/l

0.77

110

Other diseases of lip and oral mucosa

165

1158

1.43

4.65

1.7

1.6

1.52

1.23

nmol/l

1.73

123

869

Other eating disorders

2.85

4.65

2.2

2.6

1.33

1.61

nmol/l

0.44

Disorders of ocular muscles, binocular movement, accommodation and refraction

185

1315

1.40

4.60

1.7

1.16

1.26

nmol/l

0.59

142

1005

Benign paroxysmal vertigo

114

745

1.53

4.60

1.5

1.4

1.32

1.21

nmol/l

0.42

556

Other disorders of bone

480

1.67

4.60

1.5

1.6

1.21

1.31

nmol/l

0.42

352

Other diseases of arteries and capillaries

206

2.05

4.57

1.4

1.37

1.21

nmol/l

0.41

150

Pacemaker

142

903

1.46

4.54

1.3

1.41

1.19

nmol/l

0.83

101

659

Other extrapyramidal and movement disorders in other diseases

613

1.59

4.54

1.6

1.4

1.07

1.26

nmol/l

0.95

457

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

505

1.65

4.53

1.2

1.3

1.16

1.24

nmol/l

0.34

365

L04AA Selective immunosuppressants

567

1.61

4.52

1.8

1.5

1.22

1.30

nmol/l

0.21

426

Suppurative and unspecified otitis media

130

774

1.49

4.51

2.0

1.8

1.45

1.24

nmol/l

1.03

588

Zoster [herpes zoster]

445

1.69

4.50

1.5

1.4

1.29

1.24

nmol/l

0.12

324

Preterm labour and delivery

521

1.64

4.50

1.4

1.8

1.19

1.36

nmol/l

0.94

402

Assault by bodily force

174

2.14

4.49

1.5

1.6

1.05

1.29

nmol/l

0.65

136

Nail disorders

201

2.05

4.48

1.9

1.4

1.07

1.26

nmol/l

0.63

154

Abnormal results of function studies

201

2.05

4.47

1.4

1.5

1.23

1.26

nmol/l

0.05

153

Benign neoplasm of other and ill-defined parts of digestive system

424

1.70

4.45

1.8

1.4

1.24

1.26

nmol/l

0.04

308

Psoriasis

118

783

1.51

4.45

1.6

1.5

1.49

1.23

nmol/l

1.45

587

285

1.87

4.44

2.2

1.6

1.22

1.31

nmol/l

0.25

207

Psoriasis vulgaris

470

1.67

4.43

1.7

1.5

1.44

1.22

nmol/l

0.80

344

Disorders of vestibular function (Vertigo)

179

1252

1.39

4.43

1.5

1.27

1.22

nmol/l

0.25

128

945

Other problems related to primary support group, including family circumstances

216

1.99

4.41

1.6

2.0

1.40

1.33

nmol/l

0.10

171

therapeutic use

3.03

4.41

1.4

1.5

1.21

1.18

nmol/l

—

Other viral diseases

109

710

1.53

4.40

1.7

1.34

1.26

nmol/l

0.29

540

ILD, hospital admissions 3, with pneumonia sepsis

169

2.14

4.40

1.3

1.24

1.09

nmol/l

0.37

117

Diseases of peritoneum

223

1.98

4.39

2.1

1.4

1.27

1.23

nmol/l

0.07

164

Bronchitis, not specified as acute or chronic

189

2.07

4.39

1.9

1.4

1.31

1.22

nmol/l

0.17

133

Nummular dermatitis

203

2.03

4.37

1.7

1.5

1.33

1.18

nmol/l

0.40

149

Nonorganic sleeping disorders

518

1.63

4.36

1.8

1.19

1.33

nmol/l

0.64

391

Lichen simplex chronicus and prurigo

157

2.18

4.34

1.2

1.4

1.47

1.22

nmol/l

0.55

115

Paroxysmal tachycardia

278

1.80

4.34

1.6

1.7

1.35

1.32

nmol/l

0.07

210

Gestational [pregnancy-induced] hypertension

496

1.63

4.29

2.6

2.0

1.61

1.35

nmol/l

1.03

381

Other and unspecified dermatitis

203

1499

1.36

4.26

1.6

1.19

1.28

nmol/l

0.62

153

1135

Pruritus

254

1.90

4.24

1.6

1.5

1.19

1.40

nmol/l

0.53

188

Systemic connective tissue disorders

127

865

1.47

4.24

1.6

1.5

1.25

nmol/l

0.00

649

Other metabolic disorders

254

1.90

4.24

1.9

1.4

1.11

1.37

nmol/l

1.03

187

Pustulosis palmaris et plantaris

2.58

4.22

1.2

1.5

1.20

1.24

nmol/l

0.06

COPD

177

1036

1.39

4.21

1.4

1.3

1.37

1.23

nmol/l

0.78

124

760

Perforation of tympanic membrane

227

1.95

4.19

1.6

1.4

1.34

1.23

nmol/l

0.20

167

Other/unspecified synovitis and tenosynovitis

227

1.95

4.19

1.9

1.5

1.31

1.37

nmol/l

0.10

156

Convalescence

121

2.33

4.18

2.0

1.4

1.16

1.31

nmol/l

0.33

Acute alcohol intoxication

108

714

1.52

4.18

1.4

1.5

1.20

1.25

nmol/l

0.16

536

Other systemic involvement of connective tissue (FG)

591

1.56

4.17

1.4

1.5

1.23

1.24

nmol/l

0.04

449

Benign lipomatous neoplasm

116

779

1.49

4.16

1.6

1.5

1.26

1.24

nmol/l

0.09

582

Plantar fascial fibromatosis

200

2.01

4.16

2.1

1.4

1.27

1.38

nmol/l

0.28

139

Delirium, not induced by alcohol and other psychoactive substances

248

1.90

4.16

1.4

1.3

1.10

1.16

nmol/l

0.17

177

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

144

995

1.43

4.16

1.6

1.8

1.22

1.29

nmol/l

0.30

107

779

Personality and behavioural disorders due to brain disease, damage and dysfunction

5.31

4.15

1.8

1.5

1.28

1.04

nmol/l

—

Pneumonia due to other infectious organisms, not elsewhere classified

3.01

4.13

1.6

1.4

0.92

1.24

nmol/l

0.67

Mental retardation, wide definition

2.74

4.12

1.3

1.6

1.42

1.17

nmol/l

0.19

Any dementia

139

663

1.45

4.12

1.3

1.21

1.19

nmol/l

0.07

102

477

Acute gastritis

148

2.17

4.08

2.3

1.4

0.97

1.25

nmol/l

0.92

107

Spontaneous rupture of synovium and tendon

168

2.09

4.06

1.7

1.4

1.37

1.24

nmol/l

0.23

115

Gonarthrosis [arthrosis of knee](FG)

303

1357

1.29

4.06

1.5

1.4

1.30

1.22

nmol/l

0.69

227

1037

Unspecified haematuria

168

984

1.39

4.06

1.3

1.4

1.37

1.25

nmol/l

0.51

125

735

Event of undetermined intent

142

2.20

4.05

1.5

1.09

1.28

nmol/l

0.67

111

Intestinal adhesions without obstruction

189

2.02

4.02

1.4

1.21

1.16

nmol/l

0.08

136

Other and unspecified effects of external causes

101

664

1.52

4.02

1.6

1.8

1.14

1.30

nmol/l

0.80

501

Car occupant injured in other and unspecified transport accidents

445

1.65

4.00

2.0

1.7

1.21

1.30

nmol/l

0.26

336

Viral warts

231

1.91

4.00

2.2

1.5

1.13

1.26

nmol/l

0.30

170

Other disorders of the musculoskeletal system and connective tissue

347

1.74

4.00

1.6

1.4

1.24

1.28

nmol/l

0.12

252

severe traumatic brain injury, does not include concussion

562

1.57

3.99

1.4

1.12

1.20

nmol/l

0.31

413

Postpartum care and examination

176

1.86

3.99

2.5

2.0

1.31

1.44

nmol/l

0.29

131

D07AA Corticosteroids, weak (group I)

332

1.75

3.98

1.8

1.12

1.35

nmol/l

0.93

246

Chronic viral hepatitis

105

2.40

3.98

1.7

1.8

1.44

1.20

nmol/l

0.28

Ulcerative colitis, NAS

326

1.75

3.95

1.6

1.15

1.26

nmol/l

0.45

239

Syphilis, including avohilmo

3.16

3.94

1.9

1.6

1.35

1.20

nmol/l

—

Syphilis

3.16

3.94

1.9

1.6

1.35

1.20

nmol/l

—

Retention of urine

138

780

1.43

3.93

1.3

1.12

1.25

nmol/l

0.68

582

Symptoms and signs involving speech and voice

124

855

1.45

3.92

1.8

1.5

1.27

1.25

nmol/l

0.09

647

Eating disorder

131

2.22

3.90

2.4

2.3

1.34

1.50

nmol/l

0.29

103

Other endocrine disorders

2.59

3.90

1.3

1.7

1.39

1.07

nmol/l

0.28

Benign neoplasm: Adrenal gland

185

2.01

3.88

1.3

1.4

1.29

1.21

nmol/l

0.16

130

Other diseases of blood and blood-forming organs

158

2.10

3.88

1.5

1.4

1.82

1.24

nmol/l

1.33

115

Abnormal weight loss

213

1.93

3.86

1.8

1.4

1.23

1.21

nmol/l

0.01

156

Mental retardation

2.71

3.85

1.2

1.7

1.48

1.18

nmol/l

0.22

Postprocedural musculoskeletal disorders, not elsewhere classified

172

2.05

3.85

1.7

1.4

1.06

1.21

nmol/l

0.39

122

Unspecified acute lower respiratory infection

389

1.68

3.84

1.8

1.5

1.53

1.18

nmol/l

0.97

286

Cerebral palsy and other paralytic syndromes

256

1.84

3.83

1.4

1.59

1.21

nmol/l

1.00

184

Urticaria and erythema

131

917

1.43

3.82

1.9

1.7

1.15

1.28

nmol/l

0.67

703

Pustular psoriasis

101

2.39

3.82

1.2

1.5

1.18

1.25

nmol/l

0.12

Asthma/COPD (KELA code 203)

367

1975

1.24

3.81

1.6

1.25

1.27

nmol/l

0.10

280

1509

Other epidermal thickening

2.44

3.81

1.3

1.5

0.88

1.35

nmol/l

1.72

Subjective visual disturbances

625

1.52

3.80

1.7

1.6

1.29

1.30

nmol/l

0.03

470

Mild mental retardation

3.21

3.78

1.2

1.6

1.99

1.15

nmol/l

—

Stomatitis and related lesions

460

1.61

3.78

1.5

1.6

1.61

1.30

nmol/l

1.04

336

Cholecystitis

301

1.77

3.78

1.5

1.3

1.19

1.24

nmol/l

0.14

219

Diseases of male genital organs

215

810

1.34

3.77

1.4

1.13

1.27

nmol/l

1.03

158

616

Other infective otitis externa

140

2.16

3.77

1.8

1.4

1.59

1.27

nmol/l

0.48

107

Convergence insufficiency and excess

4.65

3.76

1.4

2.0

1.00

1.23

nmol/l

0.45

Other diseases of blood and blood-forming organs, wide

548

1.56

3.73

1.6

1.4

1.53

1.26

nmol/l

1.40

406

Psychotic depression

2.41

3.72

1.9

1.5

1.21

1.35

nmol/l

0.23

Urticaria

107

725

1.48

3.72

1.8

1.7

1.14

1.28

nmol/l

0.69

552

Keratitis

140

998

1.41

3.71

1.5

1.6

1.28

1.25

nmol/l

0.07

103

768

Speech and linguistic disorders

129

2.16

3.66

1.3

2.3

1.17

1.31

nmol/l

0.19

Use of pramipexole

527

1.56

3.66

1.5

1.4

1.39

1.21

nmol/l

0.66

386

Spondylosis

199

1169

1.33

3.65

1.5

1.4

1.21

1.28

nmol/l

0.42

153

881

Diaphragmatic hernia

137

976

1.41

3.65

1.5

1.3

1.31

1.22

nmol/l

0.35

104

731

Other chronic obstructive pulmonary disease

168

1009

1.36

3.64

1.4

1.3

1.40

1.24

nmol/l

0.85

116

739

Disorders of parathyroid gland

460

1.59

3.61

1.3

1.49

1.26

nmol/l

0.68

336

Malignant neoplasm of respiratory system and intrathoracic organs

483

0.50

3.60

1.1

1.3

1.28

nmol/l

0.00

350

Allergic asthma (mode), excluding more controls

462

1.59

3.60

2.1

1.9

1.27

nmol/l

0.01

361

Ulcerative enterocolitis

2.77

3.59

1.7

1.6

0.91

1.32

nmol/l

0.94

Ovarian cyst

105

401

1.50

3.58

1.8

1.31

1.27

nmol/l

0.12

311

Corns and callosities

150

2.08

3.57

1.6

1.4

1.26

1.33

nmol/l

0.13

106

Diseases of inner ear

204

1485

1.32

3.55

1.5

1.27

1.25

nmol/l

0.05

147

1120

Injury, poisoning and certain other consequences of external causes

182

673

1.36

3.52

1.6

1.7

1.23

1.34

nmol/l

0.58

140

535

Herpesviral [herpes simplex] infections

271

1.78

3.52

1.6

1.5

1.22

1.25

nmol/l

0.05

203

Disorders of sclera, cornea, iris and ciliary body

212

1627

1.31

3.50

1.6

1.23

1.24

nmol/l

0.08

160

1239

Soft tissue disorders related to use, overuse and pressure

101

687

1.47

3.47

1.5

1.4

1.14

1.23

nmol/l

0.35

501

Spirochaetal infections, other/unspecified, including avohilmo

943

0.61

3.47

1.8

1.5

1.25

1.24

nmol/l

0.01

722

Other chronic obstructive pulmonary disease, including avohilmo

208

1305

1.31

3.46

1.4

1.36

1.25

nmol/l

0.64

144

964

Fall on and from stairs and steps

100

680

1.47

3.45

1.5

1.24

1.26

nmol/l

0.05

504

Hypertrophy of breast in women and men

448

1.59

3.45

1.8

1.29

1.34

nmol/l

0.15

348

Leiomyoma of uterus

197

831

1.33

3.44

1.5

1.8

1.24

1.34

nmol/l

0.51

137

650

Viral infections of the central nervous system

159

2.02

3.44

1.4

1.5

1.31

1.28

nmol/l

0.04

119

Chronic suppurative otitis media, including avohilmo

166

2.00

3.43

1.5

1.40

1.15

nmol/l

0.63

124

Acute suppurative otitis media

550

1.51

3.43

2.1

1.9

1.59

1.24

nmol/l

1.72

429

Other disorders of conjunctiva

341

1.68

3.42

1.4

1.10

1.17

nmol/l

0.21

251

Other noninflammatory disorders of uterus, except cervix

274

1.63

3.42

1.5

1.32

1.18

nmol/l

0.39

203

Generalized anxiety disorder

348

1.67

3.42

2.0

1.66

1.41

nmol/l

0.66

270

Weight loss

230

1.83

3.41

1.8

1.4

1.20

1.22

nmol/l

0.02

170

Vulvovaginal ulceration/inflammation in other diseases

133

2.12

3.39

1.9

2.2

1.11

1.53

nmol/l

1.46

Other arthritis (FG)

113

790

1.43

3.38

1.5

1.6

1.29

1.19

nmol/l

0.41

606

Lyme disease, including avohilmo

935

0.62

3.36

1.8

1.5

1.25

1.24

nmol/l

0.01

715

Lyme disease

935

0.62

3.36

1.8

1.5

1.25

1.24

nmol/l

0.01

715

Pediculosis, acariasis and other infestations, including avohilmo

397

1.62

3.34

2.1

1.7

1.20

1.31

nmol/l

0.25

303

Postprocedural endocrine and metabolic disorders, not elsewhere classified

232

1.82

3.32

1.9

1.5

1.09

1.38

nmol/l

1.05

171

DVT of lower extremities and pulmonary embolism

152

1117

1.36

3.31

1.5

1.4

1.40

1.21

nmol/l

1.00

113

820

Mental and behavioural disorders due to sedatives or hypnotics

155

2.01

3.29

1.3

1.6

0.79

1.27

nmol/l

2.20

126

Chronic suppurative otitis media

128

2.12

3.29

1.7

1.5

1.40

1.24

nmol/l

0.31

Allergic asthma (mode)

474

1.55

3.26

2.1

1.9

1.27

1.28

nmol/l

0.03

367

Diseases of salivary glands

119

846

1.41

3.26

1.4

1.6

1.39

1.24

nmol/l

0.56

638

Biological medicines for asthma

3.05

3.26

1.4

1.6

1.36

1.44

nmol/l

—

Umbilical hernia

112

788

1.42

3.25

1.6

1.5

1.29

1.28

nmol/l

0.04

598

Benign neoplasm of urinary organs

103

2.25

3.22

1.2

1.4

1.37

1.28

nmol/l

0.14

Other and unspecified urticaria

464

1.56

3.22

1.9

1.7

1.18

1.34

nmol/l

0.52

349

Follow-up care involving plastic surgery

2.45

3.22

1.3

1.5

1.61

1.24

nmol/l

—

Eating disorders

184

1.90

3.21

2.3

2.1

1.25

1.46

nmol/l

0.50

144

Migraine without aura

347

1.65

3.21

2.1

1.9

1.27

nmol/l

0.02

285

Other infectious diseases

171

1.94

3.18

1.7

1.4

1.25

1.22

nmol/l

0.05

123

Viral infections of the central nervous system, including avohilmo

171

1.94

3.18

1.4

1.29

1.25

nmol/l

0.06

129

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

554

0.56

3.18

1.1

1.3

1.32

1.29

nmol/l

0.04

403

Early lumbar disc prolapse, operated

221

1.82

3.18

1.3

2.0

1.25

1.38

nmol/l

0.35

167

Hypercalcemia

2.32

3.17

1.7

1.4

1.27

1.21

nmol/l

0.08

Other viral hepatitis

137

2.05

3.16

1.6

1.34

1.32

nmol/l

0.03

113

Other inflammatory liver diseases

137

2.05

3.16

1.3

1.4

1.15

1.24

nmol/l

0.23

Oral leukoplakia, including avohilmo

2.75

3.16

1.1

1.5

1.72

1.25

nmol/l

—

Gonarthrosis,primary

347

1711

1.22

3.16

1.5

1.4

1.33

1.25

nmol/l

0.70

263

1293

Ulcerative colitis

628

1.47

3.15

1.5

1.6

1.29

1.28

nmol/l

0.03

472

Colonic or urogenital fistula

101

702

1.44

3.15

1.8

1.5

1.24

1.26

nmol/l

0.05

528

Other specified/unspecified arthritis

669

1.45

3.15

1.6

1.35

1.19

nmol/l

0.64

516

Deforming dorsopathies

661

1.45

3.13

1.5

1.7

1.22

1.28

nmol/l

0.22

500

Special screening examination for infectious and parasitic diseases

297

1.60

3.12

2.9

1.9

1.81

1.29

nmol/l

1.62

250

Other arrhythmias

228

1336

1.28

3.09

1.7

1.6

1.32

1.27

nmol/l

0.24

174

1008

Complications of internal orthopaedic prosthetic devices, implants and grafts

541

1.50

3.09

1.4

1.3

1.03

1.19

nmol/l

0.86

403

Viral pneumonia (unknown virus, not influenza)

152

1.98

3.09

1.8

1.4

1.01

1.25

nmol/l

0.46

113

Glaucoma suspect

131

956

1.37

3.08

1.4

1.18

1.21

nmol/l

0.13

705

Small fibre neuropathy

2.52

3.05

1.3

1.4

1.55

1.10

nmol/l

0.40

Other viral hepatitis, including avohilmo

146

2.00

3.05

1.6

1.31

1.29

nmol/l

0.02

120

Other infectious diseases, including avohilmo

210

1.82

3.03

1.6

1.4

1.31

1.24

nmol/l

0.11

152

Other benign neoplasms of skin

134

986

1.36

3.02

1.4

1.5

1.14

1.22

nmol/l

0.33

745

Hyperparathyroidism

404

1.57

3.00

1.3

1.56

1.24

nmol/l

0.95

294

Emotional disorders and disorders of social functioning with onset specific to childhood

2.58

3.00

2.4

2.7

2.14

1.27

nmol/l

—

Persistent delusional disorders

175

1.89

2.99

1.2

1.4

1.16

1.24

nmol/l

0.23

127

Viral warts, including avohilmo

537

1.49

2.99

2.0

1.7

1.17

1.30

nmol/l

0.44

403

Pyogenic arthritis

147

1.98

2.99

1.5

1.3

1.03

1.08

nmol/l

0.08

107

COPD, hospital admission 2, with asthma infections

119

738

1.39

2.99

1.3

1.39

1.18

nmol/l

1.11

542

Other systemic involvement of connective tissue

669

1.44

2.97

1.4

1.5

1.22

1.28

nmol/l

0.20

501

Injuries to unspecified part of trunk, limb or body region

241

1.75

2.97

1.5

1.4

1.11

1.21

nmol/l

0.21

176

Malignant neoplasm of urinary organs, including Hilmo

271

1.70

2.97

1.3

1.71

1.28

nmol/l

0.66

194

Oesophagitis

107

2.16

2.96

1.9

1.4

1.50

1.20

nmol/l

0.24

Other spirochaetal diseases, including avohilmo

953

0.65

2.95

1.8

1.5

1.27

1.24

nmol/l

0.06

727

Problems related to social environment

2.84

2.92

1.5

1.7

0.63

1.11

nmol/l

—

Diverticular disease of intestine

255

1269

1.25

2.91

1.5

1.4

1.32

1.30

nmol/l

0.08

187

953

DVT of lower extremities

468

1.52

2.91

1.6

1.3

1.57

1.22

nmol/l

1.08

350

Infective dermatitis

273

1.69

2.90

1.3

1.4

1.18

1.23

nmol/l

0.13

195

Faecal incontinence

170

1.89

2.90

1.6

1.4

1.33

1.25

nmol/l

0.14

123

Alzheimer’s disease (Atypical or mixed)

196

1.82

2.89

1.3

1.25

1.08

nmol/l

0.28

133

Erosion and ectropion of cervix uteri

2.71

2.89

1.6

1.4

1.41

1.19

nmol/l

—

Colectomy operation

405

1.56

2.89

1.2

1.4

1.12

1.20

nmol/l

0.26

289

Cervicalgia

493

1.50

2.88

1.6

1.27

nmol/l

0.01

367

Benign neoplasm: Pituitary gland, craniopharyngeal duct

115

2.10

2.88

1.3

1.5

1.51

1.29

nmol/l

0.38

Paracetamol or NSAID medication

183

1.63

2.86

1.5

1.7

1.24

1.15

nmol/l

0.28

140

Idiopathic gout

222

1.76

2.85

1.2

1.3

1.65

1.12

nmol/l

2.09

156

Testicular dysfunction

2.20

2.83

1.2

1.3

1.66

1.25

nmol/l

0.51

Pilonidal cyst

193

1.82

2.83

1.4

1.6

1.40

1.38

nmol/l

0.03

143

conjunctival haemorrhage

179

1.85

2.82

1.3

1.4

1.11

1.15

nmol/l

0.07

125

Ocular pain

179

1.85

2.81

1.9

1.4

1.11

1.33

nmol/l

0.51

132

Other spirochaetal diseases

942

0.66

2.81

1.8

1.5

1.27

1.24

nmol/l

0.06

721

Open wound of wrist and hand

176

1316

1.29

2.80

1.6

1.22

1.27

nmol/l

0.20

124

1008

Burns and corrosions of external body surface, specified by site

269

1.68

2.77

1.5

1.09

1.23

nmol/l

0.28

197

Maternal care for other known or suspected fetal problems

287

1.53

2.77

2.5

2.0

1.26

1.46

nmol/l

0.77

227

Retinal vascular occlusion

224

1.75

2.77

1.2

1.3

1.20

1.26

nmol/l

0.13

168

Alcohol withdrawal state with delirium

166

1.88

2.76

1.5

1.3

1.13

1.14

nmol/l

0.02

117

Examination and encounter for administrative purposes

111

2.08

2.72

1.4

1.2

1.08

1.28

nmol/l

0.50

Other condition

356

1.58

2.71

1.7

1.5

1.45

1.21

nmol/l

0.59

263

Polyuria

574

1.45

2.71

1.8

1.3

1.23

nmol/l

0.01

427

Other predominantly sexually transmitted diseases, not elsewhere classified

364

1.57

2.71

1.9

1.43

1.40

nmol/l

0.07

282

Iridocyclitis

566

1.45

2.71

1.5

1.31

1.29

nmol/l

0.07

421

Retinal vascular disorders

226

1.73

2.69

1.2

1.3

1.20

1.26

nmol/l

0.13

169

Other and unspecified vascular occlusions

175

1.83

2.67

1.2

1.3

1.28

1.26

nmol/l

0.05

131

Schizoaffective disorder

168

1.85

2.67

1.6

1.5

1.15

1.28

nmol/l

0.31

128

Scabies, including avohilmo

334

1.59

2.67

2.3

1.8

1.21

1.35

nmol/l

0.31

255

Personal history of other diseases and conditions

196

1.78

2.66

1.9

1.48

nmol/l

0.01

155

Pain and other conditions associated with female genital organs and menstrual cycle

357

1.52

2.66

2.3

1.8

1.21

1.28

nmol/l

0.19

279

Other disorders of binocular movement

2.81

2.65

1.4

1.8

0.98

1.21

nmol/l

0.65

Radial styloid tenosynovitis [de Quervain]

106

2.08

2.63

1.6

1.5

1.07

1.36

nmol/l

0.50

Oral lichen planus, including avohilmo , including avohilmo

162

1.86

2.62

1.3

1.5

1.96

1.31

nmol/l

0.89

121

Alcohol abuse counselling and surveillance

3.37

2.61

1.5

0.89

1.26

nmol/l

—

Abscess of anal and rectal regions

206

1.75

2.61

1.6

1.5

1.15

1.31

nmol/l

0.35

157

Fracture at wrist and hand level

132

991

1.33

2.60

1.6

1.13

1.26

nmol/l

0.87

101

756

Other hearing loss

649

1.41

2.60

1.5

1.3

1.29

1.26

nmol/l

0.07

479

Allergic urticaria

177

1.81

2.59

1.5

1.18

1.32

nmol/l

0.29

132

Spondylolisthesis/Spondylolysis

417

1.51

2.57

1.5

1.32

1.30

nmol/l

0.04

305

Emotional disorders starting during childhood or adolescence

2.44

2.56

2.5

2.6

2.34

1.25

nmol/l

—

Cerebral cysts

121

1.99

2.55

2.0

1.5

1.23

1.34

nmol/l

0.11

Other disorders of optic [2nd] nerve and visual pathways

142

1.91

2.55

1.7

1.5

1.26

1.28

nmol/l

0.03

104

Carrier of infectious disease

2.75

2.55

1.4

1.7

1.42

1.16

nmol/l

—

Allergic contact dermatitis

299

1.61

2.55

1.8

1.6

1.27

1.43

nmol/l

0.45

227

Osteoporosis

579

1.41

2.55

1.7

1.4

1.12

1.25

nmol/l

0.53

416

Other menopausal disorders

319

0.58

2.54

2.1

1.6

1.41

1.25

nmol/l

0.26

240

COPD, early/later onset

169

1106

1.28

2.54

1.4

1.3

1.40

1.23

nmol/l

0.97

116

822

Erosion of teeth , including avohilmo

683

1.39

2.53

1.6

1.8

1.34

1.33

nmol/l

0.03

517

Other viral diseases, including avohilmo

132

989

1.32

2.53

1.7

1.8

1.33

1.27

nmol/l

0.29

766

Conjunctivitis (acute, non atopic)

100

722

1.38

2.53

1.6

1.7

1.35

1.26

nmol/l

0.28

549

Mental disorders, not otherwise specified

164

1.84

2.53

1.4

1.8

1.39

1.30

nmol/l

0.13

126

Other and unspecified myopathies

201

1.75

2.52

1.2

1.4

1.85

1.12

nmol/l

1.76

141

Testicular hypofunction

2.17

2.51

1.2

1.3

1.84

1.32

nmol/l

0.63

Viral meningitis

2.28

2.51

1.3

1.6

1.26

1.39

nmol/l

0.16

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

626

1.41

2.51

1.6

2.0

1.34

1.33

nmol/l

0.02

487

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

136

1.92

2.50

1.2

1.6

1.23

1.35

nmol/l

0.24

106

Type1 diabetes, definitions combined, early onset

101

2.08

2.50

3.0

2.0

0.44

1.32

nmol/l

4.65

Puerperal sepsis

262

1.65

2.50

1.7

1.58

1.36

nmol/l

0.41

196

Other interstitial pulmonary diseases

348

1.56

2.50

1.5

1.3

1.20

1.18

nmol/l

0.03

246

Superficial injury of thorax

372

1.54

2.49

1.9

1.4

1.20

nmol/l

0.02

268

Pregnancy with abortive outcome

195

801

1.27

2.49

1.9

1.8

1.42

1.33

nmol/l

0.51

148

614

Mycoses, including avohilmo

345

2211

1.19

2.49

1.6

1.26

1.29

nmol/l

0.13

254

1697

Malignant neoplasm of bronchus and lung, including Hilmo

480

0.59

2.48

1.1

1.3

1.29

1.28

nmol/l

0.01

347

Fracture of shoulder and upper arm

131

992

1.32

2.48

1.4

1.5

1.14

1.26

nmol/l

0.54

733

Duodenal ulcer

217

1.71

2.47

1.4

1.3

1.30

1.17

nmol/l

0.26

155

Varicose veins

212

1285

1.25

2.47

1.4

1.14

1.25

nmol/l

0.91

152

981

Inflammatory bowel disease

116

865

1.34

2.47

1.5

1.7

1.30

1.27

nmol/l

0.09

659

Medical abortion

186

791

1.27

2.46

1.8

1.39

1.33

nmol/l

0.29

147

606

Degenerative diseases of the nervous system

116

618

1.35

2.46

1.3

1.21

1.18

nmol/l

0.08

443

Other necrotizing vasculopathies (FG)

123

1.96

2.45

2.3

1.3

1.15

nmol/l

0.00

Interstitial lung disease

350

1.55

2.44

1.5

1.3

1.20

1.18

nmol/l

0.04

248

Interstitial lung disease endpoints

350

1.55

2.44

1.5

1.3

1.20

1.18

nmol/l

0.04

248

Radiculopathy

358

1.54

2.44

1.1

1.4

1.19

1.26

nmol/l

0.21

263

Injury of unspecified body region

181

1.78

2.43

1.1

1.4

1.08

1.19

nmol/l

0.21

131

COPD, hospital admissions

166

1095

1.28

2.43

1.4

1.3

1.39

1.23

nmol/l

0.94

114

814

Abnormal serum enzyme levels

116

837

1.34

2.42

1.3

1.29

1.26

nmol/l

0.10

100

603

ILD, hospital admissions

343

1.55

2.42

1.5

1.3

1.21

1.19

nmol/l

0.06

243

Other disorders of veins

144

1093

1.30

2.42

1.7

1.5

1.34

1.24

nmol/l

0.41

840

Corneal ulcer

448

1.48

2.41

1.7

1.6

1.23

1.24

nmol/l

0.01

331

Polymyalgia rheumatica

296

1.59

2.41

1.1

1.3

1.21

1.11

nmol/l

0.27

211

Acute and subacute iridocyclitis

473

1.46

2.40

1.5

1.26

1.27

nmol/l

0.02

352

Exposure to other and unspecified inanimate mechanical forces

182

1.77

2.39

1.6

1.5

1.11

1.34

nmol/l

0.84

136

Unspecific neurodegenerative disorder

138

721

1.31

2.39

1.2

1.3

1.20

nmol/l

0.01

524

Malignant neoplasm of kidney, except renal pelvis

212

1.70

2.39

1.3

1.82

1.23

nmol/l

0.67

152

Malignant neoplasm of urinary organs

235

1.67

2.38

1.3

1.78

1.25

nmol/l

0.69

167

Viral meningitis, including avohilmo

2.22

2.38

1.3

1.6

1.26

1.42

nmol/l

0.20

Extrapyramidal and movement disorders

135

1036

1.31

2.37

1.6

1.4

1.15

1.22

nmol/l

0.28

773

Disorders of optic nerve and visual pathways

205

1.71

2.37

1.6

1.5

1.23

1.28

nmol/l

0.10

150

Myeloproliferative diseases (CML excluded)

168

1.79

2.36

1.4

1.3

1.35

1.19

nmol/l

0.39

120

Myeloproliferative diseases

183

1.76

2.35

1.4

1.28

1.19

nmol/l

0.20

134

Astigmatism

139

1.88

2.35

1.9

1.7

1.06

1.23

nmol/l

0.34

102

Psoriasis (vulgaris), strict definition

2.27

2.34

1.8

1.5

1.44

1.27

nmol/l

—

Symptoms and signs involving the skin and subcutaneous tissue

263

2058

1.21

2.34

1.7

1.6

1.27

1.28

nmol/l

0.10

200

1560

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

154

1.83

2.34

1.5

1.3

1.17

nmol/l

0.00

108

Viral hepatitis

169

1.78

2.32

1.6

1.32

1.27

nmol/l

0.06

136

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

395

1.50

2.32

1.4

1.7

1.22

1.27

nmol/l

0.14

295

Superficial injury of abdomen, lower back and pelvis

363

1.52

2.31

1.6

1.7

1.52

1.26

nmol/l

0.57

274

Sequelae of other external causes

133

1.89

2.31

1.4

0.97

1.24

nmol/l

0.62

100

Pneumonia due to Streptococcus pneumoniae

2.19

2.31

1.5

1.4

1.03

1.21

nmol/l

0.35

Glaucoma

201

1377

1.24

2.31

1.4

1.19

1.26

nmol/l

0.32

140

1027

Dislocation, sprain and strain of joints and ligaments of knee

219

1613

1.23

2.31

1.6

1.7

1.39

1.29

nmol/l

0.72

171

1254

Pneumonitis due to solids and liquids

177

1.76

2.29

1.2

1.4

1.02

1.10

nmol/l

0.16

128

Unspecified event, undetermined intent

2.47

2.28

1.4

1.6

1.13

1.33

nmol/l

—

Early lumbar disc prolapse operation

246

1.63

2.27

1.4

1.8

1.25

1.38

nmol/l

0.33

192

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

141

1.85

2.27

1.5

1.8

0.68

1.27

nmol/l

2.17

115

Other bursopathies

285

1.58

2.27

1.6

1.4

1.25

1.27

nmol/l

0.03

202

Venous thromboembolism

191

1482

1.24

2.26

1.5

1.35

1.24

nmol/l

0.61

141

1103

Other disorders of nervous system

156

1.80

2.25

1.3

1.4

1.10

1.24

nmol/l

0.26

108

Fracture of lumbar spine and pelvis

545

1.41

2.25

1.4

1.3

1.21

nmol/l

0.00

396

Abnormal findings on antenatal screening of mother

106

1.99

2.25

2.7

2.2

1.25

1.44

nmol/l

0.36

Use of other anti-dementia drugs

492

1.39

2.23

1.2

1.3

1.30

1.14

nmol/l

0.43

352

Use of memantine

492

1.39

2.23

1.2

1.3

1.30

1.14

nmol/l

0.43

352

Other complications of surgical and medical care, not elsewhere classified

209

1.68

2.22

1.5

1.4

1.00

1.23

nmol/l

0.81

152

Any death

240

1383

1.21

2.21

1.2

1.4

1.17

1.27

nmol/l

0.76

177

1023

Ulcerative rectosigmoiditis

202

1.69

2.21

1.3

1.4

1.30

1.29

nmol/l

0.02

152

Dermatitis due to substances taken internally

121

1.91

2.20

1.7

1.5

1.52

1.31

nmol/l

0.26

Acute and transient psychotic disorders

264

1.60

2.20

1.6

1.5

1.03

1.20

nmol/l

0.65

192

Noninflammatory disorders of female genital tract

110

410

1.35

2.19

2.0

1.8

1.39

1.28

nmol/l

0.34

319

Strabismus

632

1.38

2.19

1.6

1.7

1.23

1.31

nmol/l

0.23

468

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

241

1.62

2.18

1.3

1.74

1.26

nmol/l

0.61

175

Ulcerative colitis (strict definition, require KELA)

409

1.47

2.18

1.4

1.7

1.21

1.26

nmol/l

0.18

304

Infections with a predominantly sexual mode of transmission

101

753

1.34

2.17

2.1

1.8

1.34

1.33

nmol/l

0.03

580

Tobacco use

122

1.89

2.16

1.4

1.5

1.43

1.31

nmol/l

0.21

Injury of muscle and tendon at shoulder and upper arm level

140

1096

1.28

2.15

1.4

1.22

1.27

nmol/l

0.26

114

811

Non-small cell lung cancer

237

0.42

2.15

1.0

1.3

1.44

1.22

nmol/l

—

171

Viral hepatitis, including avohilmo

181

1.72

2.15

1.6

1.30

1.27

nmol/l

0.04

145

Non-small cell lung cancer, adenocarcinoma, helper endpoint

149

0.33

2.14

1.0

1.4

1.97

1.13

nmol/l

—

104

166

0.36

2.13

1.3

2.4

1.60

nmol/l

—

134

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

104

783

1.33

2.13

1.8

1.7

1.16

1.26

nmol/l

0.47

609

Alzheimer disease, including avohilmo

116

610

1.32

2.12

1.2

1.3

1.20

1.18

nmol/l

0.06

441

Other disorders of eyelid

153

1146

1.26

2.08

1.4

1.29

1.25

nmol/l

0.15

118

852

Ganglion

464

1.42

2.06

1.3

1.7

1.46

1.32

nmol/l

0.41

346

Other obstructed labour

139

1.80

2.04

1.4

1.7

1.28

1.46

nmol/l

0.29

106

Other follicular disorders

184

1.69

2.04

2.1

1.5

1.46

1.32

nmol/l

0.25

141

Malignant neoplasm of breast, ER-negative, including Hilmo

461

0.61

2.02

1.5

1.23

1.29

nmol/l

0.10

349

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.06

2.01

1.8

1.5

0.99

1.48

nmol/l

—

Other disorders of eye and adnexa

327

1.50

2.00

1.7

1.6

1.05

1.33

nmol/l

0.99

243

Disorders of continuity of bone

232

1.60

1.98

2.3

1.4

1.01

1.30

nmol/l

1.57

171

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

320

1.50

1.97

1.8

1.4

1.33

1.24

nmol/l

0.25

233

Other symptoms and signs involving general sensations and perceptions

2.09

1.96

1.0

1.3

0.87

1.12

nmol/l

—

Superficial injury of forearm

225

1.60

1.96

2.1

1.7

1.31

1.27

nmol/l

0.05

169

Pyoderma gangrenosum

4.60

1.95

1.6

1.7

1.10

0.46

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

362

1.47

1.94

1.8

1.7

1.35

1.31

nmol/l

0.07

275

Alzheimer disease

100

540

1.33

1.94

1.2

1.3

1.27

1.17

nmol/l

0.31

387

Benign neoplasm: Ascending colon

346

1.48

1.93

1.5

1.4

1.29

1.18

nmol/l

0.21

249

Secondary malignant neoplasm of respiratory and digestive organs

2.75

1.93

1.3

1.6

0.92

1.18

nmol/l

—

Asthma, hospital admissions , main diagnosis only

289

2143

1.17

1.92

1.6

1.32

1.28

nmol/l

0.22

223

1628

Asthma and allergy, excluding more controls

231

1.58

1.92

2.3

2.2

1.41

1.28

nmol/l

0.22

184

Other disorders of white blood cells

113

1.87

1.91

1.5

1.4

1.54

1.23

nmol/l

0.44

Misadventures to patients during surgical and medical care

331

1.48

1.90

1.5

1.4

1.14

1.24

nmol/l

0.28

240

Deviated nasal septum

122

955

1.28

1.90

1.5

1.52

1.25

nmol/l

1.51

725

Seborrhoeic dermatitis

243

1.57

1.89

1.5

1.06

1.22

nmol/l

0.53

179

Glucosamine medication

1011

0.76

1.88

1.4

1.3

1.31

1.23

nmol/l

0.28

744

Non-small cell lung cancer, adenocarcinoma

141

0.35

1.88

1.0

1.3

1.97

1.18

nmol/l

—

106

Disorders of tooth development and eruption

262

1.49

1.87

1.6

1.7

1.36

1.24

nmol/l

0.25

207

Malignant neoplasm

315

1581

1.17

1.87

1.5

1.6

1.14

1.29

nmol/l

1.83

230

1200

Primary hyperparathyroidism

252

1.55

1.86

1.4

1.62

1.21

nmol/l

0.96

177

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

330

2217

1.16

1.86

1.7

1.6

1.25

1.28

nmol/l

0.23

243

1701

Anterior Iridocyclitis

508

1.38

1.86

1.5

1.27

1.26

nmol/l

0.03

375

Diseases of tongue

107

1.87

1.86

1.5

1.2

1.34

1.16

nmol/l

0.27

Other complications of labour and delivery, not elsewhere classified

175

0.45

1.85

3.1

2.2

1.25

1.56

nmol/l

—

140

Other necrotizing vasculopathies

159

1.70

1.85

2.1

1.3

1.13

1.19

nmol/l

0.12

113

Crohn disease

301

1.50

1.84

1.3

1.7

1.22

1.26

nmol/l

0.11

225

Malignant neoplasm, wide definition

322

1612

1.16

1.83

1.5

1.6

1.19

1.29

nmol/l

1.00

238

1224

Liquid cancers, including Hilmo

131

916

1.26

1.83

1.6

1.4

1.23

1.27

nmol/l

0.15

664

Benign neoplasm: Skin of eyelid, including canthus

359

1.45

1.82

1.6

1.4

1.39

1.25

nmol/l

0.36

258

ILD, hospital admissions 1, main diag only

318

1.48

1.82

1.5

1.3

1.24

1.18

nmol/l

0.13

226

Malignant neoplasm

315

1585

1.16

1.82

1.5

1.6

1.14

1.29

nmol/l

1.82

231

1202

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.13

1.82

1.2

1.5

1.43

1.31

nmol/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

130

1.77

1.81

1.1

1.4

1.16

1.23

nmol/l

0.09

Coagulation defects, purpura and other haemorrhagic conditions

460

1.39

1.80

1.4

1.5

1.30

1.29

nmol/l

0.04

338

Disorders of refraction and accommodation

706

1.31

1.80

1.8

1.13

1.29

nmol/l

0.80

528

Bullous disorders

123

1.80

1.4

1.09

1.08

nmol/l

0.03

Unspecified dementia

171

1.63

1.79

1.3

1.32

1.03

nmol/l

0.92

121

COPD, hospital admissions 1, only main diagnosis

117

789

1.28

1.79

1.4

1.3

1.38

1.20

nmol/l

0.79

580

Female genital prolapse

318

1.37

1.78

1.7

1.6

1.04

1.27

nmol/l

1.38

239

Benign neoplasm: Caecum

247

1.54

1.78

1.4

1.27

1.18

nmol/l

0.13

175

Childhood asthma (age<16), excluding more controls

185

1.56

1.78

2.2

2.3

1.41

1.36

nmol/l

0.06

147

Malignant neoplasm, including Hilmo

321

1612

1.16

1.78

1.5

1.6

1.20

1.30

nmol/l

0.87

237

1225

Injury of eye and orbit

345

1.45

1.77

1.7

1.06

1.30

nmol/l

1.09

254

Chronic sinusitis

144

1161

1.24

1.77

1.8

1.6

1.41

1.24

nmol/l

0.89

112

882

Other skin changes

496

1.37

1.77

1.4

1.30

1.25

nmol/l

0.15

368

Trochanteric bursitis

296

1.49

1.76

1.5

1.24

1.27

nmol/l

0.06

213

Acute pharyngitis

358

1.44

1.76

2.0

1.9

1.23

1.27

nmol/l

0.09

272

5-aminosalicylic acid

539

1.36

1.76

1.5

1.7

1.19

1.29

nmol/l

0.41

408

Glomerulonephritis

224

1.57

1.75

1.2

1.4

1.72

1.23

nmol/l

0.90

166

Cushing syndrome

3.36

1.75

1.0

1.8

1.71

0.91

nmol/l

—

Scleritis

3.36

1.75

1.5

1.9

1.31

1.00

nmol/l

—

HSIL lesion of the vagina

3.36

1.75

2.0

2.3

1.24

1.19

nmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

463

1.38

1.75

1.8

2.0

1.37

1.43

nmol/l

0.13

358

Benign neoplasm: Descending colon

162

1.67

1.74

1.3

1.4

1.31

1.15

nmol/l

0.25

112

Asthma and allergy

237

1.54

1.74

2.3

2.2

1.41

1.31

nmol/l

0.17

188

All dysplastic lesions of the vagina

2.24

1.74

3.0

1.7

1.15

1.30

nmol/l

0.19

Enthesopathies of lower limb, excluding foot

549

1.35

1.73

1.6

1.7

1.06

1.30

nmol/l

1.20

418

Osteonecrosis due to drugs

2.94

1.72

1.6

1.8

1.16

0.89

nmol/l

—

Burn and corrosion of trunk

2.14

1.72

1.5

0.70

1.17

nmol/l

—

Childhood asthma (age<16)

187

1.55

1.71

2.2

2.3

1.41

1.38

nmol/l

0.03

149

!Aliquae complicationes praecoces traumatis

1.88

1.70

2.6

1.4

0.83

1.24

nmol/l

1.10

Early complications of trauma

1.88

1.70

2.6

1.4

0.83

1.24

nmol/l

1.10

Ptosis of eyelid

258

1.52

1.70

1.3

1.4

1.34

1.21

nmol/l

0.25

183

Herpesviral keratitis and keratoconjunctivitis

1.92

1.70

1.3

1.5

1.18

1.26

nmol/l

0.09

Complications of labour and delivery

171

778

1.22

1.69

1.9

1.7

1.36

nmol/l

0.01

136

590

Budesonide

332

1.45

1.69

1.6

1.5

1.23

1.32

nmol/l

0.22

247

Schizophrenia

383

1.41

1.67

1.2

1.5

1.20

1.23

nmol/l

0.08

278

Trigeminal neuralgia

119

1.77

1.66

1.6

1.4

1.50

1.32

nmol/l

0.32

Complications predominantly related to the puerperium

554

1.34

1.65

2.1

2.0

1.35

1.38

nmol/l

0.06

437

Other specified/unspecified dorsopathies

2.04

1.65

1.3

1.5

1.37

1.30

nmol/l

—

Malignant neoplasm of breast, HER-negative

435

0.64

1.64

1.6

1.5

1.23

1.29

nmol/l

0.10

326

Injuries to the neck

581

1.33

1.63

1.6

1.7

1.20

1.30

nmol/l

0.34

436

Dermatophytosis

343

1.43

1.63

1.3

1.4

1.19

1.22

nmol/l

0.06

248

Inflammatory disease of uterus

277

1.48

1.63

2.0

2.1

1.50

1.43

nmol/l

0.13

211

Paralytic strabismus

158

1.65

1.62

1.3

1.4

1.00

1.20

nmol/l

0.42

108

Need for other prophylactic measures

133

0.37

1.61

1.2

1.5

1.56

1.26

nmol/l

—

Coxarthrosis

176

941

1.21

1.61

1.3

1.4

1.13

1.21

nmol/l

0.40

124

716

Nonsuppurative otitis media

429

1.36

1.61

2.0

1.9

1.62

1.25

nmol/l

1.28

331

ILD medications: azathioprine

328

1.44

1.59

1.6

1.13

1.29

nmol/l

0.39

252

Visual field defects

190

1.58

1.59

1.5

1.4

1.29

1.20

nmol/l

0.19

134

Synovial cyst of popliteal space [Baker]

136

1.70

1.58

1.8

1.4

1.21

nmol/l

0.00

Pulmonary heart disease, diseases of pulmonary circulation

104

822

1.27

1.57

1.5

1.4

1.29

1.23

nmol/l

0.19

604

Palmar fascial fibromatosis [Dupuytren]

346

1.42

1.57

1.4

1.3

1.25

1.19

nmol/l

0.12

251

Thyroiditis, ILD-related definition

239

1.51

1.56

2.3

1.6

1.27

1.33

nmol/l

0.12

176

Retinal detachments and breaks

112

894

1.25

1.56

1.4

1.3

1.12

1.26

nmol/l

0.75

686

COPD, hospital admissions 3, with asthma pneumonia sepsis

598

1.29

1.55

1.3

1.39

1.19

nmol/l

0.85

434

Disturbances of skin sensation

709

1.29

1.55

1.9

1.7

1.37

1.27

nmol/l

0.32

539

Eustachian salpingitis and obstruction

176

1.60

1.54

2.3

1.7

1.68

1.28

nmol/l

0.64

135

Car occupant injured in noncollision transport accident

1.98

1.54

1.5

0.57

1.23

nmol/l

—

Carcinoma in situ of vulva

3.37

1.53

1.2

2.2

1.14

0.81

nmol/l

—

LSIL lesion of the vagina

2.61

1.52

4.1

2.1

1.37

1.30

nmol/l

—

Tinnitus

606

1.31

1.51

1.5

1.4

1.20

1.28

nmol/l

0.26

454

Contact with and exposure to communicable diseases

745

0.73

1.51

1.7

2.0

1.05

1.35

nmol/l

1.37

580

Other viral diseases, not elsewhere classified

424

1.37

1.50

1.7

1.46

1.29

nmol/l

0.57

318

Pulmonary embolism

757

1.27

1.49

1.4

1.29

1.23

nmol/l

0.18

555

Pulmonary heart disease

757

1.27

1.49

1.4

1.3

1.29

1.24

nmol/l

0.17

556

Pedal cyclist injured in other and unspecified transport accidents

283

1.45

1.49

1.8

1.5

1.82

1.22

nmol/l

0.91

205

Foreign body on external eye

409

1.37

1.49

1.5

1.09

1.18

nmol/l

0.31

308

Mixed conductive and sensorineural hearing loss

283

1.45

1.49

1.3

1.4

1.18

1.25

nmol/l

0.17

203

Other specified and unspecified retinal disorders

2.01

1.49

1.5

1.4

0.53

1.29

nmol/l

—

Polyp of the female genital tract

345

1.31

1.49

1.7

1.41

1.27

nmol/l

0.50

262

Sequelae of injuries of lower limb

226

1.51

1.48

2.2

1.4

1.12

1.27

nmol/l

0.23

163

Uterine polyps

331

1.33

1.48

1.6

1.7

1.57

1.27

nmol/l

1.27

249

Actinic keratosis

937

0.78

1.48

1.2

1.3

1.17

1.23

nmol/l

0.19

681

FESS (DNB20)

300

1.44

1.48

1.8

1.5

1.62

1.27

nmol/l

0.82

219

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

444

1.35

1.47

1.4

1.6

1.21

1.27

nmol/l

0.21

328

Presbycusis

280

1.45

1.47

1.5

1.3

1.43

1.19

nmol/l

0.37

202

Superficial injury of hip and thigh

359

1.39

1.47

1.5

1.4

1.16

1.20

nmol/l

0.11

262

Endometriosis

396

1.29

1.46

1.8

1.7

1.47

1.27

nmol/l

0.74

306

Macular pucker

343

1.40

1.46

1.4

1.3

0.91

1.24

nmol/l

2.11

259

Lichen sclerosus et atrophicus

252

1.47

1.44

1.5

1.4

1.38

1.33

nmol/l

0.09

181

Other and unspecified disorders of vitreous body

140

1130

1.21

1.44

1.7

1.4

1.21

1.26

nmol/l

0.22

849

Benign neoplasm of ovary

378

0.63

1.44

1.4

1.10

1.30

nmol/l

0.45

282

Severe visual impairment, monocular

3.15

1.44

1.0

2.0

1.55

0.87

nmol/l

—

Use of rotigotine

3.15

1.44

4.0

2.1

1.23

1.11

nmol/l

—

Malignant neoplasm of breast, including Hilmo

674

0.78

1.44

1.4

1.6

1.36

1.33

nmol/l

0.09

522

Malignant neoplasm of breast, HER2-negative, including Hilmo

674

0.78

1.44

1.4

1.6

1.36

1.33

nmol/l

0.09

522

Toxic liver disease

2.74

1.43

1.3

1.7

0.80

0.86

nmol/l

—

Contact with other sharp object(s)

156

1.61

1.43

1.6

1.40

1.38

nmol/l

0.02

116

Aneurysms, operations, SAH

370

1.38

1.42

1.5

1.3

0.98

1.22

nmol/l

1.14

271

Other noninflammatory disorders of vulva and perineum

172

1.57

1.42

1.5

1.7

1.27

1.24

nmol/l

0.04

132

Arterial embolism and thrombosis

110

1.73

1.42

1.2

1.4

1.35

1.18

nmol/l

0.24

Cardiomyopathy

421

1.36

1.42

1.4

1.3

1.59

1.17

nmol/l

0.99

303

Pollen allergy

382

1.37

1.41

1.9

2.0

1.81

1.37

nmol/l

1.38

305

Restless leg syndrome

337

1.40

1.41

1.7

1.5

1.37

1.27

nmol/l

0.17

250

Azathioprine

338

1.39

1.6

1.13

1.29

nmol/l

0.38

252

Disorders of orbit

1.78

1.39

1.6

1.5

1.25

1.31

nmol/l

0.08

Obsessive-compulsive disorder

111

1.71

1.38

1.5

2.3

1.74

1.44

nmol/l

0.44

Parkinson's disease, excluding more controls

211

1.48

1.38

1.8

1.3

1.10

1.29

nmol/l

0.52

170

Procreative management

115

769

1.23

1.38

1.9

1.7

1.23

1.22

nmol/l

0.06

573

Pleural plaque

198

1.52

1.37

1.3

1.4

1.26

1.08

nmol/l

0.43

141

Use of cabergoline

2.96

1.36

1.6

1.9

1.44

0.85

nmol/l

—

Sequelae of tuberculosis

2.95

1.36

1.2

1.3

0.96

0.95

nmol/l

—

Tonsillectomy and adenotomy

182

1074

1.18

1.36

2.1

1.8

1.31

1.29

nmol/l

0.08

142

830

Meniscus derangement

193

1091

1.17

1.36

1.6

1.5

1.27

1.20

nmol/l

0.39

151

837

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C peptide [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS